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Summary 




 Nanobiotechnology is emerging as a new interdisciplinary field studying and 
applying the nano-sciences into biotechnology and has gained increasing attraction and 
importance during the last 10 years. This field could potentially make a major impact 
on human health by revolutionizing medicine, drug delivery or tissue engineering 
applications. In particular, nanofibers have attracted the attention of biologists and 
engineers due to their resemblance to native extracellular matrix (ECM) to meet the 
demand for fabricating ideal scaffolds for tissue engineering field. Electrospinning 
technique to produce high functional nanofibers has stimulated researchers to explore 
the application of nanofiber matrix as a tissue-engineering scaffold.  
 
 My PhD project was to investigate the nanofabrication, architecture controlling and 
chemical modification of collagen scaffolds and to evaluate the first use as substrates 
for in vitro culturing human corneal cells and the subsequent potential in constructing 
corneal equivalents.  
 
 In this project, electrospinning technique was adapted to create collagen 
nanofibrous scaffolds using both the reported solvent of 1,1,1,3,3,3 hexafluoro-2-
propanol (HFP) and one safer solvent of acetic acid (HAc), which was used as an 
alternative electrospinning solvents compared with HFP. One major work of this 
project was performed to develop the electrospinning collagen and improve the quality 
of collagen nanofibers. The capacity to produce collagen nanofibers more effectively 
and safely could lead to the generation of ECM-based fabrics with applications in the 
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fields of corneal or other soft tissue engineering. Considering high degradation and low 
mechanical strength of collagen materials, a variety of crosslinking methods, such as 
glutaraldehyde (GTA), dehydrothermal treatment (DHT) and UV irradiation were 
performed to increase the biostability and mechanical strength of collagen nanofibers, 
and their effects on the physical and biological properties of nanofibers were 
investigated by in vitro culturing of corneal fibroblasts. The electrospun collagen 
scaffolds exhibited similar chemical composition and physical structure present in 
native ECM. This study showed that aqueous crosslinking brought great damage on the 
structural integrity of collagen nanofibers, while the GTA vapor, DHT or UV 
treatment could increase the biostability of the nanofibers and preserve the porous 
structure. 
 
 A novel nanofibrous collagen-GAG scaffold was constructed by electrospinning 
using a mixture of TFE and water as the dissolving solvent. The potential of applying 
the nano-scale collagen-GAG scaffolds in tissue engineering is significant since this 
nano-dimensional scaffold made of natural ECM closely mimics native ECM found in 
human body and may eventually support more active tissue regeneration. The 
incorporated GAG component was found to enhance cell growth as GAG is an 
important ECM component. This novel nanofibrous scaffold may facilitate cell-matrix 
interactions and speed up cell growth or tissue regeneration by introducing cell-
specific ligands or extracellular signaling molecules, such as peptides and 
oligosaccharides.  
 
 The aligned collagen scaffold was fabricated by one controllable electrospinning 
apparatus with a rotating wheel collector. This scaffold exhibited a distinct fiber 
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alignment compared with the random fibrous scaffold (as control) using a static plate 
collector. The elongated proliferation pattern of the cells growing on the aligned 
scaffold coincided with the cell morphology found in many native tissues, indicating 
that the controllable electrospinning technique to produce nanofibrous scaffolds with 
well-defined architecture can be very useful for engineering different specific tissues 
or organs. This study also suggests that the topography of the extracellular matrix 
(ECM) may affect cellular behavior, and controlling this environment is essential in 
the design of scaffolds for tissue engineering. Nanofibrous collagen scaffolds with 
aligned pattern architecture which assemble the structure of native cornea also have 
significant potentials for many other specific tissue engineering and organs 
regeneration applications.  
 
 The research of my project may lead to the development of novel platforms for 
generating functional soft tissues and improved cellular scaffolds through precisely 
controlling tissue assembly at the nanometer level. 
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 Damage to the cornea by injury or disease can lead to partial loss of transparency, 
or even corneal blindness when this transparency loss is irreversible. From World 
Health Organization data, there are more than 45 million individuals who are 
bilaterally blind and another 135 million that have disabling low vision [1]. This 
situation will worsen due to the aging population and the increased use of corrective 
laser surgery [2, 3]. At present, corneal blindness is corrected only by transplantation 
of donor cornea through penetrating keratoplasty [4]. However, the global donor 
shortage limits corneal transplantation and leaves millions of patients on the cornea 
donor waiting lists, and this situation is even more serious in many developing 
countries [5, 6]. In addition, corneal donor transplantation has a poor success rate for 
patients with eye disorders such as severe dry eyes, chemical burns, and multiple 
corneal graft failures [7]. It is also a hefty burden especially for average patients in 
many developing countries given the high expense of identifying potential donors, 
preserving, testing, and shipping the donor corneas [8]. For these reasons, it is of 
significance to develop an alternative corneal replacement to restore human vision by 
promising devices that can replace part of or the full thickness of damaged or diseased 
corneas. 
 
 To this aim, over the past 40 years, the development of artificial corneal 
replacements as substitutes for human donor cornea with key characteristics, such as 
biocompatibility, mechanical strength and flexibility, and nutrient transport has made 
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significant progress with the advance of modern sciences and technologies [9]. These 
kinds of studies have been especially emerging in the past decade due to the advance in 
ophthalmological techniques. Currently artificial corneal replacements can be roughly 
divided into two types: keratoprostheses (Kpros) made of synthetic polymers [10-15] 
and bio-engineered corneal cellular equivalents constructed using tissue engineering 
techniques [9, 16-18]. These artificial corneas have great potential to benefit millions 
worldwide who are blind due to corneal diseases or disorders.  
 
 Successful Kpro is yet to be achieved in clinical applications using synthetic 
polymers, with subsequent modifications to enhance biocompatibility which 
encourages biocolonization and biointegration [7, 16]. However, there is still no KPro 
with proven long-term efficacy and low complication rate. The main complication of 
KPros was and still is the spontaneous rejection of prostheses/extrusion due to the 
limited integration with the host’s body [19]. Besides, Kpro can also be only a 
temporary solution due to irreversible calcification of the synthetic polymer [14].  
 
 More recently, the rapid growth of technologies in tissue engineering may provide 
a possibility of creating an artificial cornea grown from corneal cells [17, 20, 21]. Cell-
based, tissue-engineered corneal equivalents mimic the native tissue and can integrate 
completely and naturally into the host’s body. Therefore, tissue engineered cornea may 
be a long-term solution and will play a greater role in patient treatment [16]. Currently 
3-dimensional culture systems are designed for full-thickness corneal reconstruction 
with corneal fibroblasts embedded into a collagen based scaffold, endothelial corneal 
cells layered below, and epithelial cells layered on the top of this cell-matrix composite. 
This kind of collagen based corneal construct is able to match 90% of the 
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physiological properties of a real cornea [17, 20, 21]. Nonetheless, the mechanical 
strength of the current corneal equivalent is too weak to be implantable and its 
transparency also needs further improvement for clear vision. These properties have 
been improved by utilizing some crosslinking techniques or combining potential 
biopolymers and synthetic polymers, but little clinical success has been reported for 
implant applications. It has been suggested that it is necessary to derive new clinical 
constructed cornea to improve the mechanical properties of the scaffolds by combining 
potential techniques and novel materials in order to produce a bio-implant with the 
right mechanical strength and durability. 
 
The electrospinning technique has gained attention and popularity in the last 10 
years due to an increased interest in nano-scale properties and technologies. One major 
attractive feature of electrospinning is the simplicity and inexpensive nature of its 
setup. During the electrospinning process, numerous tiny fibers with diameters on the 
order of several nanometers to micrometers overlap one another to form a porous 
structure with very high surface area per unit weight. Because its nano-scale network is 
similar to the structure of some native tissues (such as the corneal stroma), the 
electrospun structure may serve as an ideal support for scaffolding in tissue 
engineering fields. Its high surface area may also promote the cell-matrix interaction 
and enhance the nutrient and media transport and eventually lead to faster regeneration.  
 
My project responded to the current disadvantages occurring in the previous 
studies, and it was aimed to investigate novel nanofibrous scaffolds using 
electrospinning with suitable physical and biological properties for constructing 
superior corneal scaffolds as an alternative to conventional scaffolds. Collagen gel and 
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sponge may still exhibit potential in suitable corneal construction for transplantation if 
the mechanical strength and biostability of collagen could be increased significantly. 
Alternatively, one part of work was aimed to improve the physical and biological 
properties of conventional scaffolds. Specifically, the aims are: 
1. To strategetically design and develop a novel collagen nanofibrous scaffold 
using electrospinning to mimic the native cornea closely by providing 
components and dimensions similar to native ECM of cornea. 
2. To modify collagen nanofibers to achieve increased biostability and mechanical 
strength with crosslinking techniques. The aim was to overcome the problem of 
low mechanical strength and high degradation rate of collagen.  
3. By using in vitro culture corneal cells on the surface of the scaffolds, to test the 
usability of the scaffolds by assaying cell attachment and proliferation rate.  
4. And a functional dendrimer was incorporated for modifying GTA and EDC 
crosslinking of collagen in order to increase the biostability and biological 
properties of collagen gel/sponge.  
This research focuses on nanofabrication and architecture controlling of collagen 
scaffolds using electrospinning. Nano-dimension and high surface area characteristics 
of the scaffolds provided a more favorable environment for corneal cells, which may 
maximize cell-ECM interaction and promote tissue regeneration. It is postulated that 
higher cell growth and tissue regeneration may provide a higher integrated structure 
and increased strength of corneal replacements required for implantation. Their 
physical properties were characterized and their surface biological properties were 
evaluated by in vitro culturing of corneal cells scaffolds. Their in vivo and in vitro 
tissue regeneration needs to be further developed in future. 
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Background and progress on tissue engineering, especially corneal tissue 
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Chapter 2 
 
Background and literature Review 
 
2.1 Overview of tissue engineering 
 
 Trauma, age-related diseases, degenerative conditions and end-stage organ failure 
result in medical needs for tissue and organ substitutes [22]. But the increasing 
shortage of donor tissue and organs remains a major obstacle for clinical 
transplantation. For example, in the United States, about 15% of the potential 
candidates for liver or heart transplantation die while on the waiting list [23]. The cost 
of tissue loss and organ failure to health care exceed $400 billion US dollars annually 
accounting for one-half of the costs for medical treatments [24, 25]. As the post-war 
baby-boomers start to age and demand better quality-of-life standards, people will 
expect science and engineering to develop and implement strategies that address the 
challenges of disabling diseases and disorders. Dramatic advances in the fields of 
biochemistry, cellular/molecular biology, genetics, biomedical engineering and 
materials science have given rise to the remarkable new cross-disciplinary field of 
tissue engineering [26].  
 
 Tissue engineering field is the development and manipulation of laboratory-grown 
tissues or organs to replace or support the functions of defective or injured body parts 
[26, 27]. Specifically, this field as diagrammatically defined in Figure 2.1 [28] 
involves isolating or harvesting cells from donor or specimen, seeding 
synthetic/naturally derived, or engineered biomaterials with donor cells and/or growth 
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factors, culturing and implanting the scaffolds to induce and direct the growth of new 
tissue. Thus scaffold-guided regenerated tissues can be used to replace damaged or 
defective tissues, such as bone, skin, and even organs [24, 26, 29, 30]. Thus, tissue 
engineering has become a promising and important field of research, which not only 
may alleviate the shortage of donor organ or tissues available for transplant, but also 
open new perspectives for treatment of diseases [30]. 
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 Although efforts to produce artificial tissues and organs for human therapies go 
back at least 30 years, such efforts have come closer to clinical success only in the last 
10 years [31]. Bioartificial skin equivalent for skin burn therapy and subsequent 
cartilage replacement are the first two commercially available products by tissue 
engineering. More complex tissues such as bone, blood vessels and nerve still need 
more work before they can be marketed. Although tissue engineering has traditionally 
been considered a high-risk investment, more than $3.5 billion has been invested in 
worldwide research and development in tissue engineering [32, 33]. Tissue 
engineering firms have increased spending at a compound annual rate of 16% since 
1990 [34]. This emergence of significant activity can be attributed to the recent 
advances in biological science and biomaterials science, especially stem cell 
technology. Besides, the field of tissue engineering is relatively undeveloped in any 
developing countries, and an increasing investment in this area is needed to provide the 
health care sector with new opportunities and challenges, which is urgently required 
for their countries to keep pace with the advancements and technological changes 
when compared with the progress in developed nations. It is foreseeable that tissue 
engineering and its application will be a popular research topic in the 21st century.  
 
 The principles of tissue engineering are as old as interventional surgery, but new 
tools and techniques have been emerging [24, 35, 36]. Tissue engineering is an 
interdisciplinary field that blends classical engineering and the life sciences. It has 
been considered as one of the most influential new technologies for the future of 
biomedicine with great insights into mimicking tissue function and the disease state 
[37, 38]. The knowledge in polymer chemistry, materials science, chemical 
engineering, and cellular/molecular biology may all be applied to tissue engineering, 
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demonstrating the multidisciplinary approach that must be taken to solve the problem 
of tissue and organ replacement. General strategies required for tissue engineering 
include biocompatible scaffold fabrication, chemical signaling factors incorporation, 
and cell seeding and integration [27, 31, 39, 40]. The scaffold fabrication has emerged 
as a significant research direction devoted to producing finally transplantable 
tissue/organ. Tissue engineered products that can be implanted into the human body 
should be 3-dimensional substitutes that may lead to rapid host integration and 
acceptance. Therefore, the fabrication of lab-grown tissue begins with the creation of 
an artificial degradable and porous scaffold that substitutes for native ECM [41-43].  
 
 The incorporation of artificial scaffolds in tissue regeneration occurred in the early 
1980s, and designing scaffolds to promote tissue growth has received a huge amount 
of focus in recent years [44]. The function of a degradable scaffold is to act as a 
temporary support matrix for transplanted or host cells and stimulates new growth in 
the shape dictated by the scaffold so as to replace the damaged tissue. The 
requirements of scaffolds for tissue engineering are complex and specific to the 
structure and function of the targeted tissue, and thus the resultant living tissue 
constructs should mimic the replaced tissues functionally, structurally, and 
mechanically. An ideal scaffold generally should have the following characteristics [27, 
45-47]: 1) biocompatibility, not provoking any inflammatory tissue response to the 
implant; 2) biodegradability, degradable into nontoxic products, leaving the desired 
living tissue; 3) the right surface chemistry, able to provide the appropriate chemical 
signals to guide cell growth and tissue regeneration; 4) appropriate shape, size, 
porosity and mechanical strength, able to provide suitable interconnected architecture 
and a defined 3-dimensional structure for the target tissue. From an engineering and 
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biology standpoint, both scaffolds materials and fabrication techniques are crucial to 
produce the scaffolds with the above chemical and physical characteristics for specific 
goals in tissue engineering fields.  
 
2.2 Scaffold Materials 
 
 The first issue with regard to tissue engineering is the choice of suitable materials 
for scaffolding. The materials for tissue engineering could be gradually degraded and 
eventually absorbed in the body [46]. Potential materials with these characteristics 
include natural, synthetic polymers, ceramics, metals and combination of these 
materials [48-52]. Most of these materials have been used in the medical field before 
the advent of tissue engineering as a research topic, being already employed as 
bioresorbable sutures. Both naturally derived and synthetic polymers have been 
identified as common candidates for scaffold materials, while ceramics and metals are 
precluded due to their lack of biological recognition and processability.  
 
2.2.1 Natural materials 
 
 Natural derived polymers commonly used in tissue engineering include proteins 
such as collagen, gelatin, hyaluronic acid, fibrin etc. and polysaccharidic materials, 
like chitosan/chitin or glycosaminoglycans (GAGs), etc [53-55]. Naturally derived 
cellular or decelluarized tissues also belong to natural materials and are commonly 
used for cell seeding and carrier because they are comprised of native ECM in native 
conformation and composition. The main advantage for using natural materials is that 
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they contain bio-functional molecules aiding the attachment, proliferation, and 
differentiation of cells. However, natural materials often lack the mechanical strength 
and lasting enzymatic resistance. Furthermore, they might also transmit diseases.  
 
 By far the most used natural material in tissue engineering is collagen, and 
collagen based scaffold is an attractive and versatile alternative in their applications as 
discussed below.  
 
2.2.1.1 Collagen and their applications  
 Collagen itself is the most abundant and ubiquitous structural protein, constituting 
approximately 30% of all vertebrate body protein. For example, more than 90% of the 
extracellular protein in the tendon and bone, and more than 50% in the skin consist of 
collagen. Collagen is the most frequently used natural polymer for various biomedical 
applications [53, 56-58] because collagen has good mechanical properties and good 
biocompatibility as an ECM protein. Besides, collagen is minimally antigenic and the 
chain of collagen is cleaved into peptides that are nontoxic to cells after degradation.  
 
 The individual polypeptide chain of collagen contains 20 different amino acid 
sequences and gives rise to the different types of collagen labeled as Type I, Type II up 
to Type XIX [53, 59]. Different collagen types confer distinctly different biological 
characteristics to the various types of connective tissues in the body. Type I collagen is 
predominant in higher order animals especially in the skin, tendon, and bone where 
extreme forces are transmitted. Type II and type III collagen have found predominantly 
in hyaline cartilage and blood vessels respectively. The other interstitial collagen types 
occur in small quantities and are associated with specific biological structures [60]. 
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Type I collagen is the predominant type being found in the body and the subsequent 
discussion will be limited to this type.  
 
 Type I collagen molecules are comprised of three polypeptide chains wound into a 
tight triple-helix. Each chain has a repeating Glycine (Gly)-X-Y motif in which X and 
Y can be any amino acid but are frequently the amino acids proline and 
hydroxyproline, respectively (Figure 2.2a). Collagen contains information such as 
particular amino acid sequence that may facilitate cell attachment or maintenance of 
differentiated function. The collagen chains are packed or processed into microfibrils 
and covalent bonds are formed between the adjacent collagen molecules both within 
microfibrils and between adjacent microfibrils [61, 62] as shown in Figure 2.2b. These 
α-chains and triple-helix create the rigidity, stability and the right handle triple-helix of 
collagen fibrils [59]. 
 
 Collagen molecules (~300 nm long) naturally self assemble into crystals with a 
cylindrical habit. The ordering of the molecules in these crystals is well accepted to be 
in a pattern known as the D-staggered array. The D-periodicity of the fibril arises from 
side-to-side associations of triple-helical collagen molecules that are ≈ 300 nm in 
length (i.e., the molecular length = 4.4 × D) and are staggered by D. The D-stagger or 
periodicity of collagen molecules produces alternating regions of protein density in the 
fibril, which exhibits the characteristic gap and overlap appearance of fibrils. This D-
periodicity can be observed by atomic force microscopy (AFM) due to the protein 
density or height caused by gap-overlap (Figure 2.2b) or by transmission electron 
microscopy (TEM) due to stronger contrast (Figure 2.2c).  
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Figure 2.2 Assembling of collagen fibers, fibrils, and molecules, (a) primary amino 
acid sequence of collagen chain, (b)AFM micrograph of collagen (left) and schematic 
diagram of collagen fibrils (right), (c) TEM micrograph of collagen and schematic 
diagram of collagen periodicity patterns (Cited from the reference [63]). 
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 Collagen based materials have been extensively used as vehicles for transporting 
cultured skin cells or drug carries for skin replacement and burn wounds [64, 65], 
simulated cartilage and implantable carriers (for bone producing proteins) [66, 67], 
ligaments [68], blood vessels [69], and corneas [17, 70]. Collagen is also widely used 
as carrier systems for delivery of drug [71, 72], protein [73, 74] and gene [75]. Besides, 
the study of native collagen for these macromolecules delivery systems and tissue 
engineering may lead to a better understanding of pathological diseases [76, 77]. The 
concepts of high binding affinity and specificity play a critical role in targeting 
delivery. Collagen-based biomaterials are expected to become a useful matrix 
substance for various biomedical applications in the future. 
 
 Currently, the collagen used in tissue engineering applications is derived from 
animal tissues, though such use creates concerns related to the quality, purity, and 
predictability of its performance. The isolation and purification of collagen from 
collagenous tissue is achieved by using a proteolytic enzyme such as pepsin to cleave 
the telopeptides [78] or by using salt extraction to remove noncollagenous materials 
from collagen [79, 80]. Scaffolds made from (or including) collagen are fabricated by a 
variety of methods or techniques, such as acid precipitation, freeze-drying, and 
thermal/chemical crosslinking. For a variety of applications, porous, three-dimensional 
collagen sponges have been made from freeze-dried or critical-point-dried after 
formation of collagen suspension or gel [57, 81, 82]. Collagen sponge may have high 
mechanical strength, but its homogenously porous network is hard to control for 
specific tissue requirements. Alternatively fibrillar hydrogels polymerized from native 
collagen are used extensively for cell culture, and have been evaluated as supports for 
regenerating nerves and for simulated cartilage, ligament, skin, cardiac muscle, and 
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blood vessels [83-86]. For tissue engineering applications, collagen gels have a major 
advantage as they can act as a homogenous network to retain cells. But the gels have 
disadvantage of low strength and high degradation. Reinforcement with solid 
components and alignment during gelation and culture mature can improve 
performance [87, 88].  
 
 The main function of collagen is mechanical reinforcement and physical support of 
the connective tissues of vertebrates [89]. However, the application of collagen in 
tissue engineering has been limited due to its biodegradation and low mechanical 
properties for surgical handling. During in vivo application, collagen is prone to 
enzymatic attack which can result in rapid degradation of the material [57, 90]. It is 
well known crosslinking reduces the degradation rate by making the collagen 
molecules less susceptible to an enzymatic attack. In addition; the crosslinking is 
effective in improving the mechanical properties [91]. The crosslinking can be 
accomplished by various physical (e.g., UV irradiation and dehydrothermal treatment) 
or chemical (e.g., glutaraldehyde (GTA), formaldehyde, and carbodiimides) techniques 
[92-95]. Crosslinking methods concentrate on creating new additional chemical bonds 
between the collagen molecules, which reinforce the scaffold to be tougher, stronger 
and lastingly biostable, and original shape of the scaffold is also maintained. 
 
2.2.2 Synthetic materials 
 
 Synthetic materials may include ceramics, glasses, and many biodegradable 
synthetic polymers [46]. Biocompatible metals and ceramics have widely used in 
biomedical application, particularly in orthopedic tissue replacements. Typical metals 
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are stainless steels and cobalt-based or titanium-based alloys [51, 96], and ceramics are 
alumina, zirconia, calcium phosphate, which have been used in bone and dental tissue 
regeneration [52, 97, 98]. However, metal and ceramics have two major disadvantages 
due to low biodegradability and limited processability. Alternatively, synthetic 
degradable polymers have attracted an increasing attention of researchers in tissue 
engineering fields [99, 100]. The commonly used synthetic polymers are polyesters, 
polyanhydrides, polyorthoesters, polyglycolic acid (PGA), poly(lactic acid) and their 
copolymers poly[lactic-co-(glycolic acid)] (PLGA), and some of them have gained 
FDA approval for human use in a variety of applications [26, 55, 101]. Most synthetic 
polymers are degraded via chemical hydrolysis and are insensitive to enzymatic 
processes. They are thermoplastics and can be easily formed into 3-dimensional 
scaffolds with a desired microstructure, shape, and dimension by various techniques 
described above. This 3-dimensional structure is often required for many applications 
in tissue engineering [102]. These polymers have also demonstrated their ability for 
supporting cell proliferation and differentiation for a variety of cell types and tissues. 
 
 For many tissue engineering applications, one polymer cannot provide all of the 
desired biological and physical properties of the scaffold. Thus copolymerization or 
association with more than natural materials or biopolymers may allow polymers to 
possess controlled degradation rates, and result in a scaffold with a wide 
mechanical/biological stability or biocompatibility distribution for tissue engineering 
applications [103]. For example, an addition of poly-L-lactide (PLLA) into the 
poly(caprolactone) (PCL) composite could enhance the compatibility between the 
dispersed PCL domains and the PLLA matrix in drug releasing implants [104].  
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 Chemical synthesized polymers offer several advantages over natural-origin 
polymers. One major advantage of synthetic polymers is that they may exhibit specific 
functions or controlled properties as demanded. The degradation and processability of 
synthetic polymer can also vary significantly by varying chemical compositions. 
However, a significant disadvantage of synthetic polymers is the biocompatibility 
problem compared with natural polymers because some synthetic polymer will 
degrade into unfavorable products such as acids [105, 106]. Compared with natural 
polymers, synthetic polymers also lack cell-recognition signals and have generally 
high hydrophobicity that precludes efficient cell seeding [107]. Besides, synthetic 
polymers exhibit unpredictable mechanical properties during degradation [108], and 
adverse tissue interactions caused the release of monomers [109]. Efforts have been 
made to incorporate cell-adhesion peptides or naturally derived ECM into synthetic 
materials, and this combined synthetic materials with cell-recognition sites is an 
attractive strategy in tissue engineering [47, 110, 111].  
 
2.3 Scaffold fabrication techniques 
 
 In tissue engineering, the biomaterials should be processed to produce a 
provisional 3-dimensional support to interact at the molecular level with cells to 
control their function, guiding the spatially and temporally complex multicellular 
processes of tissue formation and regeneration. The scaffold fabrication techniques 
therefore need to be developed appropriately to manufacture the scaffold with the 
desired characteristics such as porosity and pore size, shape, and distribution [112]. 
Although the field of tissue engineering is less than 20 years old, a significant 
advancement in process techniques has been made in a relatively short period of time. 
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Conventional scaffold fabrication techniques to produce porous structure in the 
abovementioned polymers include phase separation, solvent casting/particulate 
leaching, gas foaming, fiber bonding, membrane lamination, melt molding, 
hydrocarbon templating etc. These techniques have been used to engineer a variety of 
tissues engineered scaffolds [46]. The choice of the suitable technique is critical to 
provide complex and specific structure and function of the tissue of interest as each 
technique has its pros and cons from a scaffold design and function viewpoint.  
 
 More recently, electrospinning has been found to be an efficient methodology to 
produce fibrous polymeric scaffolds with fiber diameters ranging from several microns 
down to nanometers. This method can provide one platform to investigate cell-matrix 
interaction and tissue regeneration by guiding cell behavior at the nano-scale and 
molecular level [113, 114]. A description of the different techniques follows. 
 
2.3.1 Phase separation 
 
 Phase separation is scaffolding processing designed with the intent of incorporating 
bioactive molecules. The polymer is dissolved in a solvent to form a homogeneous 
multicomponent system [115]. This system, under certain conditions, becomes 
thermodynamically unstable and tends to separate into more than one phase in order to 
lower the system free energy [116]. Liquid-liquid or solid-liquid phase separation is 
induced by lowering the solution temperature or by adding a non-solvent liquid. 
Subsequent removal of the solidified solvent-rich phase by sublimation leaves a porous 
polymer scaffold.  
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 One prominent advantage of phase separation is to incorporate bioactive molecules 
into the matrices without decreasing the activity of the molecule due to harsh chemical 
or thermal environments. A slight change in the parameters, such as types of polymer, 
polymer concentration, solvent/non-solvent ratio, and the most importantly, thermal 
quenching strategy, significantly affect the resultant porous scaffold morphology. 
However, porosity is often irregular under this condition. 
 
 Freeze-drying is a commonly employed phase separation technique to remove 
solvent from bulk polymer via sublimation. This process is commonly performed in a 
lyophilizer by subjecting frozen specimens to a deep vacuum, thus reducing the 
solvents’ vapor pressure. Freeze-drying is a frequently used method to fabricate a 
collagen sponge scaffold. Generally collagen is dissolved in acetic acid aqueous 
solution, thus forming collagen gel scaffold, and subsequently scaffold is lyophilized 
to remove the water and acetic acid solvent. Foam morphology with 3-dimensional and 
highly porous structure was achieved as in Figure 2.3. The specific foam morphology 
and pore distribution depend on the thermodynamic mechanism of phase separation 












Figure 2.3 Collagen scaffold formed by the freeze-drying technique; the typical pore 
diameter= approximately 100 µm. 
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2.3.2 Solvent casting/particulate leaching 
 
 Solvent casting/particulate leaching is another technique that has been widely used 
to fabricate scaffolds for tissue engineering applications [117]. This technique is based 
on the principle that salt particles can be dispersed into a polymer solution and later 
dissolved, creating a highly porous scaffold. Briefly, salt is first ground into small 
particles, and those of the desired size are transferred into a mold [118]. A polymer 
solution is then cast into the salt-filled mold. The solvent is allowed to evaporate 
leaving behind a polymer matrix with salt particle embedded throughout. Then the salt 
crystals are leached away using water to form the pores of the scaffold. The process is 
easy to carry out. The pore size can be controlled by the size of the salt crystals and the 
porosity by the salt/polymer ratio; thus this technique can produce the porous scaffolds 
with regular porosity. However, this method requires potential toxic solvents; also 
there are some concerns regarding irregularly shaped pores that may not be completely 
interconnected or uniformed distributed throughout the scaffold. Besides, the thickness 
of the scaffolds fabricated with this technique was limited. 
 
2.3.3 Gas foaming 
 
 Gas foaming is an alternative technique to create porous structures without the use 
of organic solvents. For a gas/polymer solution, pores are created by sudden 
depressurization, which induces thermodynamic instability and bubble nucleation 
[119]. This technique overcomes the necessity to use organic solvents and solid 
porogens as residues of organic solvents remaining in these polymers after processing 
may damage the transplanted cells and nearby tissue [120]. But the main problems 
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related to gas foaming technique are caused by the excessive heat used during 
compression molding prohibiting the incorporation of any temperature labile material 
into the polymer matrix and the fact that the pores do not form an interconnected 




2.3.4.1 Overview of electrospinning 
 The fabrication methods stated above have their own merits and demerits, but most 
of them are incapable of making nanofibrous scaffolds with controlled fiber diameter 
and spatial orientation. Recently, electrospinning has been shown to be an effective 
technique for the production of nanofibrous scaffolds suitable for tissue fabrication 
[123-125]. The electrospinning technique was derived from conventional fiber 
spinning techniques (e.g. melt spinning, dry spinning or wet spinning) that rely on 
mechanical forces to produce fibers by extruding polymer melt or solution through a 
spinnerette and subsequent fiber drawing of the resulting filaments as they solidify or 
coagulate. Electrospinning offers a fundamentally different approach to fiber 
production by introducing electrostatic forces to modify the fiber formation process, 
from which the word “electrospinning” was derived [126]. Early pioneering work was 
done by Formhals, who was granted the first U.S. patent for an electrospinning process 
that produced fine fibers from a cellulose acetate solution [127]. Taylor elucidated the 
transformation from a polymer droplet to a stream at the end of the needle in an 
electrospinning setup in 1969. This study led to a better understanding of the 
electrospinning process and the mechanism of the nanofibrous formation. In 1987, the 
experimental conditions and factors that cause highly conductive fluids exposed to 
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increasing voltages to produce unstable streams was studied by Hayati et al [128]. 
Numerous other studies have been done to examine the effect of changing both the 
polymer solution and the experimental setup. Based on these studies it is clear that 
characteristics such as fiber diameter, fiber morphology and the amount of beading are 
dependent upon a large number of variables. These variables include solution 
concentration, viscosity, surface tension, conductivity, and process variables, such as 
voltage, needle diameter, flow rate and needle-to-collector distance. A number of 
patents have been issued since then, directed for the most part towards the production 
non-woven fabrics. However, a review of the most recent literature confirms the 
extremely limited quantitative technical and scientific information available regarding 
the underpinnings of this process.  
 
 Modern electrospinning (as shown in Figure 2.4) is usually performed using a 
syringe filled with solvated polymer. Electrospinning generally involves the 
application of an electrostatic force between polymer solution (or melt) kept in a 
syringe or pipette and a counter metal electrode (collector plate) kept at a certain 
distance from the polymer solution. With the increase of the voltage charged on the 
polymer solution, the pendent drop of the polymer solution formed at the tip of the 
capillary is deformed into a cone, known as “Taylor’s cone”. At a critical electrical 
field when the electrostatic force overcomes the surface tension holding the droplet, 
the solution starts flowing in the form of a charged jet [112]. When this jet moves 
toward the collector, it will splay due to the electrostatic force; then the solvent 
evaporates and the compound solidifies. The anode connects to a hypodermic needle 
on the syringe and the cathode connects to a collector. When the high voltage is 
applied the Taylor cone forms, the polymer ejects from the cone apex, and the fibers 
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collect on the grounded surface. Typical operations of electrospinning include: using a 
syringe pump to control the polymer flow rate, using a rotating mandrel or disk to 
collect the fibers, manipulating the electric field, and changing the collection surface 











Figure 2.4 The schematic diagram of the electrospinning apparatus. 
 
 
2.3.4.2 Application of electrospinning in scaffold fabrication 
 Electrospinning is a very simple and versatile method of creating high functional 
and high performance polymer-based nanofibers that can revolutionise the world of 
structural materials [125]. Electrospun nanofibers may exhibit high flexibility in 
surface functionalities and superior mechanical properties compared with any other 
known forms of polymers. In recent years, electrospinning has attracted great attention 
because polymer nanofibers with high surface-to-volume ratio can be fabricated using 
this technique [129]. Electrospun and non-woven nanofibers have widely applied in 
various fields including protective clothing, filtration, drug delivery, implant interfaces, 
and scaffolds for tissue engineered devices [112, 125, 129].  
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 The potential of electrospinning for producing nano-scale or micro-scale scaffolds 
in tissue engineering is significant as it is believed that the nano-scale dimension 
provides a well-defined architecture with high surface area to volume ratio, which may 
promote tissue biosynthesis, guide cell growth, and speed up subsequent tissue 
regeneration when compared with any other known forms of gels or sponges [114, 
130-132]. Electrospun nanofibrous scaffolds of natural or synthetic polymers with a 
non-woven, porous, three-dimensional structure have been applied in tissue 
engineering exhibiting excellent cell adhesion and proliferation [133].  
 
 Most nanofibers obtained so far are in non-woven form, which can be useful for 
relatively small number of applications. It is necessary to have some control on the 
collecting electrospun fibers during depositing into the collector. The ability to 
fabricate fiber architecture with controlled alignment will increase the potential 
application of electrospinning. For example, some specific tissue or ECM exhibits 
well-defined structure, and there is need for alignment control during electrospinning 
to produce patterned nanofibrous analogs.  
 
 Many techniques to obtain aligned fiber patterns have been attempted as shown in 
Figure 2.5. One common way is to use one rotating cylinder collector (Figure 2.5a). 
The fibers alignment can be formed as the fibers could be oriented circumferentially 
around the rotating cylinder. High speeds up to thousands of rpms (revolutions per 
minute) are always needed to produce acceptable alignment of fibers. To make use of 
the electrostatic charge of the electrospinning jet, another electrostatic field can be 
used to increase the alignment of fibers as an auxiliary electrical field [126, 134] as 
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shown in Figure 2.5b. The alignment of the fibers is limited using the cylinder due to 
low rotating speed rate. By using a knife edge disk as show in Figure 2.5c, 
significantly high alignment could be achieved due to high rotating speed of the disk 


















Figure 2.5 Schematic drawing of the different electrospinning collectors, (a) a rotating 
cylinder collector, (b) a rotating cylinder collector with an auxiliary electrical field, (c) 
a knife edge disk, (d) two parallel conducting collector. 
 
 As an alternative to mechanically rotating the form for the fiber patterning, the 
electrospun fibers could form the alignment in the auxiliary electrostatic field, which 
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was achieved by the gap of two opposite electrodes [135]. The aligned fibers were 
easily removed from the collector as the fibers were supported by the two electrodes 
with one gap (Figure 2.5d). One advantage of this collector over previous setups is the 
easy removal of the sample from the collector. But this method is not suitable for 
patterning a large or thick sample as over charges on the deposited fibers may lead to 
repulsion, which decreases the alignment of the fibers. 
 
 It is still challengeable to design suitable scaffolds such as grafts or implants using 
tissue engineering approaches that completely mimic the structures and properties of 
natural ones. The combination of polymer chemistry and material processing 
techniques provides pathways for the fabrication of highly complex and functional 
matrices. The next generation scaffolds should be designed according to the micro-
architecture and macro-architecture of target tissue, and will be fabricated by utilizing 
various scaffold fabrication techniques with both right component and right structure 
to provide suitable strength, pore size and porosity, degradation properties, and cellular 
properties. The scaffolds could stimulate specific cellular responses at the molecular 
level. They should be also bioresorable and can be tailored to suit specific tissues. The 
ideal scaffolds would be resorbed at the same rate as tissue regeneration and be strong 
enough to withstand loading where necessary [27]. 
 
2.4 Tissue engineered cornea  
2.4.1 Overview of corneal structure, diseases and replacements  
 
 If eyes are the windows of the soul, the corneas are the panes of those windows. 
They shield the eye from dust and germs. The structure of cornea is shown in Figure 
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2.6. Being the main optical element of the eye, the cornea forms one sixth of the 
circumference of the eye ball and has a radius of 7.8 mm, allowing for the efficient 
transmission and focusing of light into the eye [136]. The cornea acts as the eye’s 
outermost lens, contributing up to 70% of the eye’s focusing power. The cornea is one 
of the most highly differentiated connective tissues and is composed of five different 
functional and structural layers from top to down: Epithelium, Bowman’s layer, stroma, 
Descemet’s membrane and endothelium [17]. There are three main cellular layers 
among the five structural layers: outer stratified epithelium, stromal keratocytes 
networked within a hydrated, mainly collagen matrix; and inner endothelial layer. 












Figure 2.6 The structure of eye (left) and cornea (right). 
 
 The epithelium accounts for 10% of the corneal thickness and provides a protective 
semipermeable barrier function especially protecting the stroma. The stroma, which 
comprises 90% of the cornea thickness, consists of tiny diameter collagen fibrils 
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arranged in a highly ordered lattice structure. This collagen's unique shape, 
arrangement, and spacing are essential in producing the cornea's light-conducting 
transparency and they also give the cornea its strength, elasticity, and form [137]. 
Under the stroma, the inner endothelium, being monolayer thin and the innermost layer 
of the cornea, is significant in keeping the stroma clear by pumping excess fluid out of 
the stroma [138].  
 
 This unique structure of the cornea allows it to serve as an optical part and a barrier 
to the outside ocular system. These functions are achieved only when the cornea is 
healthy i.e. all the layers are free of any cloudy or opaque area [136]. However, any 
disease, injury, or cellular failure of the layers may cause opacification and disorders, 
resulting in visual impairment and even blindness in some cases [8]. There are more 
than 45 million individuals who are bilaterally blind and another 135 million that have 
severely impaired vision in both eyes based on World Health Organization data. 
Besides, this situation will worsen due to the aging population and overwhelmingly 
popular use of corrective laser surgery for patients to reduce dependency on glasses 
and contact lenses [139, 140].  
 
 Currently the only effective treatment of corneal blindness is transplantation with 
human donor cornea, and this transplantation is highly effective with a success surgery 
rate of 90%. However, corneal donor shortage is a global problem, especially in 
developing countries which limits the rate of the transplantation [141]. The 
transplantation is also a heavy burden for many patients due to the high expense of 
identifying potential donors, preserving, testing, and shipping the donor corneas. In 
addition, corneal donor transplantation has a poor success rate for patients with some 
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kinds of disorders such as severe dry eyes, chemical burn, and multiple corneal graft 
failures [7]. Consequently it is of significance to develop an alternative corneal 
replacement with an artificial substitute which may fulfill the functions of the native 
cornea it replaces; i.e., transparency, refraction, and protection. Over the past 40 years, 
there is an increasing interest in the design of an artificial replacement of cornea in the 
form of a synthetic keratoprosthesis (Kpro) [14, 142] and more recently of the bio-
engineered cornea [9]. These efforts may be able to tackle worldwide shortage for 
transplantation.  
 
 Despite two centuries of recorded attempts, the history of KPros, first developed in 
1796, generally consists of a succession of failures [19, 143-145]. The KPros of the 
previous century, made of glass or quartz, were eventually abandoned because of the 
high incidence of extrusion. Since the 1990s, attempts to improve biocompatibility, 
hydrophilic properties, and flexibility have resulted in the use of a range of polymer-
based materials including poly(methacrylate) (PMMA), polytertrafluoroethylene 
(PTFE), polyurethane, and hydrogels [7, 19, 144, 146-148]. One successful Kpro has 
been achieved using one device consisting of a spongy porous outer skirt element and 
optical concentric core with interpenetrating polymer network integrating each other. 
Subsequent modifications to enhance biocompatibility encourage bio-colonization and 
bio-integration, which lowers rejection and complication rate [7, 16]. However, there is 
still no KPro with proven long-term efficacy and low complication rate.  
 
 More recently, the rapid growth of technologies in tissue engineering and stem cell 
technology may provide the possibility to create an artificial cornea grown from 
genetically-modified cells. Besides, in the long-term, cell-based, tissue-engineered 
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corneal equivalents mimic the native tissue and can integrate completely and naturally 
into the host’s body, which will play a greater role in patient treatment [16]. But tissue 
engineering of corneal equivalents for wounded or diseased corneas is a relatively new 
technique and is still at the investigatory stage [17, 21]. 
 
2.4.2 Cellular selection 
 
 In constructing a corneal replacement, the first step is to harvest each specific type 
of cells near the cornea and determine the best cell source for tissue reconstruction, 
which may be able to regenerate the target tissue or produce a differentiated progeny. 
This is a difficult task and may be the reason why the corresponding corneal 
transplants often fail [149, 150]. These failures include the inability to grow certain 
types of cells in vitro, the tendency of many cell types to differentiate with an 
increasing number of cell passages, and the potential variations that may occur related 
to the age and health condition of the donor, and sometimes the difficulty in obtaining 
adequate biopsy specimens of some tissues from normal human donors. Cell selection 
work includes the isolation, culture, and expansion of each corneal cell type on 
scaffolding substrates before three-dimensional tissue reconstruction. 
 
 The corneal epithelial cells are derived from the limbal stem cells by dispase 
digestion, and these stem cells are restricted to the limbus, the transitional zone 
surrounding the central cornea [17]. The optimal environment for maxium isolation 
efficiency and the survival of the epithelial cells are important. Keratocytes (or corneal 
stromal fibroblasts) generally are cultured from stromal explants after dispase 
digestion and removal of the epithelim and endothelium. Alternatively, corneal 
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keratocytes can be obtained from keratocyte contamination in epithelial cell cultures 
by changing the culture medium for keratocyte culture medium. The endothelial cells 
are one of the constraints in the development of engineered cornea since its 
proliferation capacity is very low and the cells are easily damaged during harvesting 
[151-153]. Improved methods of the proliferation, differentiation and cytopreservation 
of endothelium are being investigated to retain the proliferation capacity of the cells 
[154].  
 
 To ensure a reliable culturing of corneal cells, the following criteria should be met: 
1) Healthy self-renewing cells; 2) Bioactive and nonimmunogenic substrates with 
appropriate properties to promote cell differentiation/integration and tissue formation; 
3) An in vitro culture condition that mimic the in vivo environment [31]. 
 
2.4.3 Recent progress on corneal tissue engineering 
 
 Corneal tissue engineering is the development and manipulation of laboratory-
grown cornea or a corneal cellular composite to replace part or the full thickness of 
damaged or diseased corneas. Recently, various methods have been attempted for the 
construction of transplantable individual layer or full-thickness of cornea, and some 
have exhibited a potential treatment for many pathological cases and lab use [18, 155].  
 
2.4.3.1 Reconstruction of individual layers of cornea  
 
 Corneal endothelium reconstruction: Insler M.S. et al. conducted the in vitro 
reconstruction of corneal endothelium by incubating corneal endothelial cells on the 
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endothelial ECM [156]. Their resultant endothelium revealed an intact monolayer of 
contact-inhibited cells with the hexagonal mosaic typical of corneal endothelium in 
vivo and improved intercellular contact compared with corneas incubated for only 24-
48 hr. Sumide T. et al. constructed a human corneal endothelial cell sheets harvested 




















Figure 2.7 Schematic illustration of human corneal endothelial cell sheet harvest on 
patterned temperature-responsive culture dishes (Cited from reference [157]). 
Chapter 2 
   33
 
 As shown in Figure 2.7, human corneal endothelial cells were seeded on the 
patterned dishes, and the cells adhered and grew only in temperature-responsive 
central area at 37°C to reach cell confluence. The cultured human corneal endothelial 
cells could be harvested as an intact 18-mm diameter monolayer sheet by temperature 
reduction to 20°C. The temperature reduction without enzymatic treatment ensured an 
intact monolayer cell sheets due to the support and bonding of the ECM. This cell 
sheet is significant for clinical application in ocular reconstructive surgery with similar 
ex vivo morphological and function to the native corneal endothelium. These 
techniques may overcome the lack of proliferation capacity of corneal endothelial cells 
in vivo. But this kind cell sheet is very weak and too easily broken for clinical handing.  
 
 It has been suggested that selection of the ideal synthetic ECM is the key to 
providing intact and functional endothelium for in vitro reconstruction of corneal 
endothelium before implantation [158, 159].  
 
 Corneal epithelium reconstruction: Several methods for transplanting epithelial 
sheets have been reported. Han B. et al. have prepared artificial ocular surface tissue 
comprising human corneal epithelial stem cells in a cross-linked fibrin gel [160]. This 
tissue engineered epithelium exhibited some functions of native tissue, but normal 
stratification and optical clarity are limited. Amniotic membrane was widely used as a 
carrier for stratified epithelial cells in vitro. This cultivated corneal epithelium can 
functionally reconstruct the cornea with limbal stem cell deficiency [161]. Co-
culturing with 3T3 feeder cells and a liquid-air interface provides a 5-to 6-layer 
epithelium that expresses keratins 3 and 12. These cell sheets have tight junction 
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formation at the superficial cell layer as well as other morphological characteristics of 
differentiated corneal epithelium. The increased in vitro and in vivo proliferating 
ability lead to enhanced graft survival and regeneration of the surface after clinical 
transplantation. However, the pigment deposits and vascularization due to the use of 
amniotic membrane have been reported within the deep layers of the cornea. In 
addition, amniotic membrane is susceptible to infectious contamination and 
transmission.  
 
 The temperature-sensitive polymer also has been used in harvesting of stratified 
corneal epithelium reported by Nishida K. et al. in which the exotic and potential 
contamination was avoided without the cell carrier [162]. The main issue of corneal 
epithelial transplantation is a loss of transplanted epithelium due to epithelial rejection 
and persistent epithelial defect which generally results in conjunctivalization. But if the 
corneal stroma remain sufficient transparency, further regrafting opportunities and 
visual recovery are possible [163].   
 
 Corneal stroma reconstruction: Stroma comprises 90% thickness of cornea and its 
architectural arrangement primarily determine the transparency of the cornea [137]. 
The reconstruction of stroma will provide the main strength and clarity of cornea [56, 
155]. Besides, the stroma will influence the survival of corneal epithelium and 
endothelium. Commonly used material used for stromal construction is natural derived 
collagen due to excellent biological activity which promotes adhesion, transport and 
growth of corneal cells. The model for stroma reconstruction was first optimized for 
skin [164]. As collagen itself is the main component of stroma, its combination with 
other ECM components such as GAGs may provide a similar proliferating 
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environment to the native one and give necessary chemical signal and stimuli for 
corneal cell growth. Many investigators have examined cell-matrix interactions 
between cultured corneal fibroblasts and collagen gel which is the main model for the 
construction of corneal stroma [155, 165]. The research demonstrated that the balance 
of collagen synthesis and degradation which could be mediate by corneal fibroblasts in 
the presence of some protein kinase activators and inhibitors may maintain stromal 
integrity [166].  
 
 However, poor mechanical properties and immune responses of collagen have 
converted the attention of researchers to some potential synthetic polymer or their 
biopolymer associated with natural material. Blended polymers may be effective in the 
early stages of stromal replacement. Collagen based composites that were blended with 
synthetic acrylamide-based polymers [poly(N-isopropylacrylamide)] were used for cell 
delivery systems in the ocular stromal reconstruction in vivo [56]. The combination of 
biological and synthetic mimics was evaluated in the study in vitro and in vivo and the 
successful growth of stromal fibroblasts was reported, but its biological activity needs 
to be improved. Hu X. J. et al. explored the feasibility of reconstructing corneal stroma 
by culture of keratocytes on polyglycolic acid (PGA) [167]. The keratocytes adhere, 
extend themselves, and proliferate well on PGA, and the cells secreted and deposited 
the new ECM. However, the cell-composite have low transparency and the tissue 
regenerating environment needs to be improved.  
 
2.4.3.2 Reconstruction of full-thickness cornea  
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 In recent years, there has been a significant progress in the development of tissue 
engineered corneal equivalents with full-thickness [16, 17, 164, 168, 169]. Most 
artificial full-thickness corneas use three-dimensional co-culture of the three corneal 
types and biomaterials. Some results have already found potential uses in biomedical 
world as animal substitutions for toxicology testing and pharmacological studies, and 
as cell-cell and cell-matrix interactions for corneal wound healing. Current efforts are 
mostly focused in developing a suitable replacement for corneal transplant [170]. 
 
 Griffith et al. constructed a corneal equivalent using immortalized corneal cell 
lines for constructing on a 3-layer corneal model collagen-based scaffold [16, 21, 31]. 
Collagen-based materials are cross-linked with glutaraldehyde (GTA) to produce a gel 
or sponge which the keratocytes are seeded in, and subsequently the corneal epithelial 
and endothelial cells. Before being used in the three-dimensional model, each cell line 
was compared with post-mortem human corneal cells with electrophysiological, 
biochemical and morphological properties. The artificial corneas cultured for 2 weeks 
in a medium containing vitamin C stimulated collagen production, and protease 
inhibitors slowed degradation of the collagen matrix. The resulting corneal equivalent 
model has key morphological and functional properties of natural corneas. The 
resultant artificial cornea is found to behave similarly to a native cornea with respect to 
morphology, transparency, and some responses to drugs and chemicals as shown in 
Figure 2.8.  
 
 However this corneal equivalent is too weak for implantation since this scaffold is 
only a random crosslinked collagen gel matrix [171]. Currently, Griffith and her 
colleagues are developing a new corneal scaffold from collagen and synthetic 
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copolymer which is designed to match with the native cornea in terms of size, shape, 
clarity, and incorporates of a peptide known to promote cell growth [56, 170]. But the 
device is still un-implantable due to lacking long-term stability and acceptable 


















Figure 2.8 Comparison of physical and chemical analysis of human cornea and 
artificial corneal equivalent, (A-C): morphology comparison, (D-F): morphology 
change after chemical treatment, (G-I): transmission change for native cornea, artificial 
corneal equivalent, and treated equivalent (Cited from reference [21]). 
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 Germain L. et al. used a similar strategy, except that either type I bovine collagen, 
or a mixture of Type I and III human collagen was used as the biomatrix (a collagen 
gel containing fibroblasts) [17, 20]. This model was first optimized for skin 
reconstruction. As shown in Figure 2.9, corneal stromal cells are dispersed into Type I 
or Type III collagen by homogenization, and cellular stroma with gel form is achieved 
in petri dish after 1h gelation and 4 days mature. Their human corneal replacement 
shows appropriate histology and expression of basement membrane components and 
integrins, and provides a tools for further physiological, toxicological and 











Figure 2.9 Procedures of the production of reconstructed cornea and a macroscopic 
view of the reconstructed cornea (Revision cited from the reference [17]). 
 
 In improving the optical, biological and mechanical properties of the scaffold for 
corneal equivalents, scientists have found that the addition of glycosaminoglycans 
(GAGs), such as chondroitin sulfate, can decrease the contraction of the collagen 
matrix and also enhance its transparency and toughness [172]. The corneal equivalents 
built on this scaffold can also respond to chemical wounding, reflecting their biological 
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resemblance with the native tissue. This collagen matrix, however, is too soft to be 
implantable. A unique crosslinking process was designed by syringe pumping to 
provide complete mixing of collagen and chemical crosslinkers as shown in Figure 
2.10. Thus the increased strength and transparency of corneal implant was achieved. 
But some further tests need to be investigated before clinical use. Synthetic polymers 
blended with collagen or surface-modified with collagen have also been investigated as 
alternative substrates. But these research are also at the investigatory stage and no 









Figure 2.10 Syringe mixing system for crosslinking (A) and resultant corneal-shaped 
implant (B) (Cited from the reference [174]).  
 
 The development of corneal replacements constructed in vitro has allowed 
researchers to conduct pharmaceutical testing and biomedical research including drug 
permeation studies, investigation of pathologic ocular conditions, and toxicological 
screening of compounds. However, although partial mimicking of the human cornea 
has been developed, a full-thickness, functional, and transplantable human corneal 
equivalent has not been achieved to date, and the use of engineered corneas for 
transplantation is still not feasible. Further design and development are necessary in 
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order to produce a bio-implant with the increased mechanical strength and durability as 
a native cornea suitable for transplantation. It is a new research direction to fabricate 
new biomaterials/composite or novel technique which can be used in the development 
of corneal replacements.  
 
2.5 The potential of electrospinning in corneal scaffolding 
 
 From the above literature review, the clinical ramification for an alternative to 
donor corneal tissue has attracted much interest in finding a new corneal replacement 
in recent years. A corneal replacement, whether it is a tissue engineered equivalent or 
synthetic keratoprosthesis, must fulfill the functions of the native cornea it replaces, i.e. 
transparency, refraction, and protection. A wide range of implants and biomedical 
devices have been developed in an attempt to correct corneal blindness, but the 
limitations of existing devices are evident when reviewing artificial cornea surgery 
reports. For tissue engineered corneal equivalents, their mechanical, optical and 
biological properties require further improvement. New techniques and new materials 
used in developing new scaffolds are of particular interest and significance to mimic. 
 
 The corneal stroma layer, which constitutes to 90% thickness of a native cornea, is 
the key structure providing the optical refraction and mechanical strength of a cornea. 
The corneal stroma is made up of 75% - 80% water on a wet weight basis and the 
remaining solid (20%) constitutes mainly the ubiquitous collagen [175]. Stromal 
collagen fibrils exist in broad belts called lamellae which run approximately parallel to 
the corneal surface. In human, about 200 of these lamellae make up the stroma and the 
structure is similar to the structure of a plywood. Each lamella itself is formed by 
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parallel collagen fibrils with fixed spacing between each other (Figure 2.11). The 
spacings are maintained by bridges made of glycosaminoglycan (GAGs) and 
proteoglycans (PGs) [176, 177]. The GAGs, 4% - 4.5% of the dry weight of the cornea, 
are predominantly keratan sulphate (60%) and chondroitin (dermatan) sulphates (25%). 
GAGs maintain the hydration level of the corneal stroma which should be constant. 
GAGs are also a key factor in determining the transparency of a cornea [178, 179]. 
Though complete knowledge is currently not know, Type I collagen is believed to be 
the essential collagen in the corneal stroma [180]. The native corneal stroma is 
composed of multiple sheets of collagen fibrils aligned in same direction within each 
layer in Figure 2.11. This heterogenic alignment of the collagen fibrils has been 












Figure 2.11 The ordered collagen fibrils crosslinked with GAG small globules in one 
layer corneal stroma (Revision cited from the reference [177]). 
 
 To date, however, the development of engineered stroma is still less than 
sophisticated. It is typically formed by random crosslinking of collagen solution. This 
process generates an anisotropic polymeric network of collagen, which is very 
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different from the collagen network found in the native cornea. This anisotropic 
network cannot sustain much mechanical stress, and thus the current engineered cornea 
is not suitable for surgical implantation. Though some alignment can be achieved by 
varying the pH and ionic electrolyte [181] or loading strain [182] during collagen self-
assembly, its alignment orientation is very limited and difficult to control.  
 
 To recapitulate the proper function and organization of native tissue in tissue 
engineering approaches, it is important to closely mimic tissue properties at the nano-
scale. Therefore, the scaffolds for tissue engineered cornea would need to have 
features similar to natural architecture and organized nanofibers in the native ECM of 
the cornea. Electrospinning of collagen may bring the advantage of not only the 
chemical and biological function of native ECM, but also bring the similarity in the 
size scale of native ECM. Besides, this nanofabrication technique could be used to 
provide nanofibrous surface topography for controlling cell behavior and tissue 
regeneration. The diameter of electrospun collagen nanofibers is approximately 50-200 
nm currently and is fairly close to that in native corneal cornea (30 nm). The diameter 
of electrospun fibers can be decreased more with further improvements of the 
electrospinning process.  
 
 Aligned nanofibrous scaffolds can also be fabricated by controllable 
electrospinning to mimic the native architecture in the corneal stroma with lamella 
formation and ordered fibrillar arrangement  [175]. It is known that this unique 
organization of the stromal collagen fibrils is a particularly important ultrastructural 
feature that may influence the shape, biomechanical properties, and transparency of 
cornea [183]. Electrospun nanofibrous scaffolds of collagen-based materials with a 
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well-defined architecture may overcome the defects of current collagen-based matrices 
and scaffolds, including poor mechanical properties and low transparency due to 
random structure. For corneal tissue engineering, the behavior of cell growth on the 
aligned collagen is of great significance because corneal stroma consists of layers of 
the aligned collagen matrices, and thus aligned patterning may influence cells behavior 
or tissue function during tissue maturing. This study was the first one comparing the 
behavior of conjunctival cells adhesion and proliferation between aligned and random 
collagen nanofibers. Besides the aligned scaffold in this study not only provides a 
regular topography, but also exhibits mechanical stimuli due to the mechanical 
stretching of the fibers induced during electrospinning.  
 
 Though it is hard to build the biomimicking structure similar to the sophisticated 
structure of native cornea, the effort of this project may provide a good start for 
fabricating novel corneal scaffolds. The understanding of nanofibrous scaffold design 
and cell-matrix interaction achieved in this project may be helpful to building an 
effective scaffold that has suitable mechanical, optical and biological properties for 
constructing a superior scaffold as a vital alternative to the conventional corneal 
scaffold. It may lead us to one step closer to construction of real corneal equivalents 
for corneal blindness. Although much work needs to be done in understanding the 
biological mechanism associated with the effects of surface topography or nano-
environment on cell behavior, the ability to engineer these properties of the scaffolds 
has been useful for applications in tissue engineering fields. 
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Chapter 3 
 
Non-aqueous crosslinking of electrospun collagen 
nanofibers: the effects on physical properties of 
nanofibers and in vitro fibroblast culture 
 
3.1 Introduction  
 
 Collagen is the most abundant protein or ECM in our body. It is found in most 
tissues including the heart, eye, blood vessels, skin, cartilage and bone, and it gives 
these tissues their structural strength [53, 59]. The use of collagen in biomedical 
application has grown rapidly due to its excellent biocompatibility [53]. Many 
techniques have been developed in fabricating collagen materials for specific medical 
applications. A number of works have been conducted in the fabrication of collagen 
nanofibers by electrospinning [113, 184-187]. The nano-dimension of electrospun 
nanofibers mimics closely native extracellular matrix (ECM) found in the human body 
[188]. The high porosity and surface area characteristic of the scaffolds may maximize 
cell-ECM interaction and promote tissue regeneration faster than other conventional 
scaffolds such as collagen sponges and gels [185, 187]. Besides, controllable 
electrospinning technique can fabricate a well-defined architecture to guide cell 
integration as ordered ECM structures are found in many native tissues [114, 189, 190]. 
Biomedical applications of collagen nanofibers are currently limited by the rapid 
degradation and low mechanical properties of collagen. The degradation of collagen 
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can reduced using various crosslinking methods to form intermolecular bonds to 
increase the biostability and mechanical properties [57, 70, 191].  
 
 Glutaraldehyde (GTA), formaldehyde, adipyl chloride, hexamethylene 
diisocyanate, and carbodiimide are among the many agents used in chemical 
crosslinking of collagen [192]. Though the mechanism of crosslinking is complex and 
poorly understood, there are two basic reactions for the chemical crosslinking. 
Reagents such as GTA, formaldehyde and diisocyanate introduce crosslinkages 
between two amino groups from lysine and hydroxylysine residues [57]. The reaction 
scheme of GTA is shown in Figure 3.1a. GTA is the most widely used crosslinking 
reagent for its effectiveness and simple procedure, but it is often cited to be undesirable 
because GTA crosslinked collagen evokes cytotoxic response due to the release of 
residual GTA and its aldehyde derivatives during degradation. In addition, the GTA 
crosslinking can be complex because different structure of GTA may exist in aqueous 
media and lead to a variety of side reactions [57, 193].  
 
 Other common reagents like carbodiimide, cyanamide, and acyl azide introduce 
amide bonds between two carboxylic groups from aspartic or glutamic acid residues 
[194]. Crosslinking with carbodiimides, such as 1-ethyl-3-(3-dimethyl aminopropyl) 
carbodiimide (EDC), can be enhanced by the addition of hydroxysuccinimide (NHS) 
to yield non-cytotoxic and more compatible matrices [195-197] because no chemical is 
incorporated into the bridges between collagen molecules (Figure 3.1b). The 
physicochemical and biological properties of the scaffolds after crosslinking have also 
been described extensively [198, 199].  
 
Chapter 3 

















Figure 3.1 Crosslinking of collagen by the different crosslinkers or methods, (a) GTA, 
(b) EDC and NHS, (c) DHT treatment, (d) UV irradiation.  
 
 Physical crosslinking methods such as dehydrothermal treatment (DHT) and 
ultraviolet irradiation (UV) can be used to crosslinking collagen. DHT treatment 
causes the formation of an amide bond between an amino group of one molecule and 
the carboxyl group of adjacent molecules (Figure 3.1c). This treatment can avoid 
potentially cytotoxic reaction products from chemical agents and provides moderate 
strength and resorption rate. UV irradiation initiates the free radical formation on 
aromatic acid residues such as tyrosine and phenylalanine (254nm) [200, 201] and 
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forms crosslinkages when these radicals react (Figure 3.1d). UV irradiation is also 
non-cytotoxic, and a more rapid and effective crosslinking can be achieved than DHT 
treatment [202], but the number of aromatic amino acid residues may limit the rate and 
extent of UV crosslinking of collagen. Besides, chain scission likely becomes a 
substantial side reaction resulting a denaturation of collagen [95, 195, 202]. 
  
 Biological crosslinking such as the use microbial enzyme transglutaminase has also 
been attempted for crosslinking collagen [203]. The calcium-dependent 
transglutaminase can catalyze acyl-transfer reaction in which γ-carboxamide groups of 
glutamine residues act as the acyl donor and the ε-amino groups of lysine residues or 
some naturally occurring primary amino groups are the acyl acceptors [204]. The 
crosslinking of collagen can be achieved as a result of the formation of intermolecular 
or intramolecular ε−(γ−glutamyl)lysine bonds. However, there are limited references 
reported on this crosslinking of collagen and the in vitro and in vivo effect. Their 
crosslinking reactions are sensitive to environment factors such as pH, temperature, 
calcium ionic concentration, and the purity of transglutaminase. As a result, high 
degree of collagen crosslinking using biological agents is still a challenge [205].  
 
 In order to maintain the 3-dimensional and nano-scale topography for sufficient 
mechanical support and cell-scaffold integration, crosslinking of collagen nanofibrous 
scaffolds is a necessary step. Our unpublished data showed that collagen nanofibrous 
scaffolds swell and collapse into a dense membrane structure quickly in aqueous media. 
This initial erosion of collagen nanofibers can not be avoided in aqueous media even 
using strong crosslinking reagents such as GTA, where the crosslinking efficiency is 
well-known. Therefore, commonly used crosslinking methods in aqueous form may 
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not be suitable for crosslinking collagen nanofibers, and thus non-aqueous form of 
crosslinking were attempted in this study.  
 
 In this chapter, GTA vapor, UV and DHT were used as the non-aqueous 
crosslinking treatments on collagen nanofibers. The impacts of the crosslinking 
treatments on physical and biological properties of the nanofibers were analyzed and 
compared. Besides, DHT treatment at high temperature of 200°C was conducted to 
crosslinking collagen. At such high temperature, efficient crosslinking reaction and 
thermal interfiber bonding were expected to provide higher biostability and mechanical 
strength of collagen as required for many biomedical applications. Samples crosslinked 
with aqueous GTA solution were used as a control.  
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3.2 Experimental section 
 
3.2.1 Materials and reagents 
 
 All chemicals and reagents were purchased from Sigma-Aldrich unless specified 
separately. Main chemicals and reagents used in this study included calf skin type I 
collagen, 1,1,3,3,3 hexafluoro-2-propanol (HFP), glutaraldehyde (GTA), glycine (Alfa 
Aesar), 3-(4,5-dimethylazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide (MTT), type I 
collagenase from clostridium histolyticum, micro BCATM protein assay kit (Pierce), 
Dulbecco’s modified eagle’s medium (DMEM, Gibco), and fetal bovine serum (FBS, 
Hyclone).  
 
3.2.2 Electrospinning of collagen nanofibers  
 
 The typical electrospinning set-up shown in Figure 2.4 was used to fabricate 
collagen nanofibers. Calf skin type I collagen was dissolved in HFP at a concentration 
of 60-100 mg/ml. The collagen suspension was placed into a 3 ml syringe fitted to a 
27½G needle. A syringe pump was used to feed the collagen solution into the needle 
tip at a feed rate of 1.0-2.0 ml/h. A voltage of 10-20 kV was applied across the solution 
and the collector, and the distance between the needle and the collector was 12 cm. 
During electrospinning, the suspension flew in the form of a charged jet toward the 
collector. As solvent evaporated, the solidified nanofibers were collected on 15 mm 
diameter glass coverslips sitting on the collector. The resultant samples were placed 
under vacuum overnight for the removal of residual solvent.  
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3.2.3 Crosslinking of collagen nanofibers  
 
 GTA vapor crosslinking was conducted in one sealed glass desiccator containing 
20 ml of aqueous 15 v/v% GTA solution. Scaffolds were exposed to the saturated GTA 
vapor by placement on a ceramic grid in the desiccator. Excess GTA vapor were 
purged periodically to avoid vapor condensation, which may lead to fiber erosion and 
scaffold distortion. For control, the electrospun collagen nanofibrous scaffold was 
exposed to 0.02% (v/v) GTA aqueous solution for 24 h crosslinking. All the GTA 
crosslinked scaffolds were soaked in 0.02 M glycine solution for 1 h to quench 
unreacted GTA and subsequently rinsing with deionized water 2 times to remove 
residual glycine.  
 
 For DHT crosslinking, heating durations were predetermined respectively for two 
different temperatures of 100°C and 200°C. Scaffolds placed in a glass petri dish were 
subjected to a vacuum (< 0.15 mBar) and preheated up to the two different 
temperatures (100°C for 2 days and 200°C for 30 min). After crosslinking, the vacuum 
was released and the samples were cooled to room temperature immediately under N2 
to avoid the oxidation of collagen. Slight temperature difference between the actual 
temperature of the sample and the oven temperature setting possibly occurred due to 
the heat transfer limitations.  
 
 UV irradiation was conducted by placing the collagen scaffolds in a UV chamber 
(Intelli-Ray 400, 254nm), in which the samples were exposed to 400W UV light for 
30min. The distance between the light source and sample was 40 cm and the intensity 
of UV was 185 mW/cm2.  
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3.2.4 Surface characterization 
 
 The surface morphology of the noncrosslinked and the crosslinked collagen 
nanofibers was visualized by a scanning electronic microscope (SEM, JEOL 6320) or a 
field emission scanning electronic microscope (FESEM, JEOL S4100) when a high 
magnification was needed. Platinum was sputtered onto the surface of the samples 
before SEM/FESEM scanning. The diameters of the fibers were measured from SEM 
images with a custom code image analysis program (Image J; National Institutes of 
Health). 
 
3.2.5 Collagenase digestion test 
 
 In vitro degradation of collagen scaffolds was performed by collagenase (activity 
of 394 Umg-1). The amount of collagen digested from the scaffolds was measured by 
the BCA total protein assay as the following: Firstly, accurately weighed collagen 
samples were soaked in collagenase solution (0.1 mg/ml PBS) at 37°C for up to 5 days. 
At predetermined time points, 25 µl of supernatant was transferred to a 96-well plate 
containing 200 µl/well BCA reagent. The plate was placed at 37°C for 30 min, then 
cooled to room temperature for 20 min and read immediately using a microplate reader 
at 540 nm wavelength (GENios, Tecan). The amount of the digested collagen was 
determined by comparison with the standards of the known protein concentration. 
 
3.2.6 In vitro cell culture   
 
3.2.6.1 Cell isolation and culture conditions 
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 Human conjunctival fibroblasts (HCFs) were obtained from human conjunctiva at 
the Singapore Eye Research Institute. Human conjunctiva tissue was carefully cut into 
0.5 to 1mm pieces and explanted on tissue culture dishes in the presence of DMEM 
medium, supplemented with 10% FBS, 100 U/ml penicillin, and 100 µg/ml 
streptomycin. The explants were inoculated in cell culture dish. The volume of 
medium was just sufficient to submerge the explant pieces. The cells were incubated at 
37°C and 5% CO2, with medium changed every two days. When the initial outgrowth 
of cells from the explants occurred, the volume of medium was increased to fully 
immerse the explants. Cells were cultured for 2 weeks to confluent before additional 
subculturing. The cells used for in vitro testing in the study were between passage 2 
and 4. The cells were incubated at 37°C and 5% CO2, with DMEM medium 
supplemented with 10% FBS and 100 U/ml penicillin. Cells were cultured for 2 weeks 
to confluent before additional subculturing.  
 
3.2.6.2 Cell culture 
 For in vitro cell culture, the scaffolds were inserted into 24-well tissue culture 
plates and positioned by stainless steel rings. HCFs were seeded into the wells at a 
density of 5X103 cells/well and were incubated in a 5% CO2 incubator at 37°C. The 
fibroblast culture medium was replaced every three days. The degree of cell 
proliferation on the scaffolds was assayed by the standard MTT assay [206] after 2 and 
7 days incubation. Briefly, the scaffolds attached with cells were incubated in a 
mixture of 360 µl of medium and 40 µl MTT solution (5 mg/ml) in phosphate buffered 
saline (PBS) for 4 h at 37°C and 5% CO2. The intense red colored formazan derivative 
formed was dissolved with 400 µl dimethyl sulfoxide for 15 min and the absorbance 
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was measured at 570 nm with a microplate reader (GENios, Tecan). The relative cell 
viability (%) on the different scaffolds was determined by comparing with a control. 
 
 The morphology of the adherent cells on the various scaffolds after 3 days culture 
was studied using SEM. To prepare the samples for SEM analysis, the samples were 
fixed by immersion in 2.5% GTA solution for 4 h followed by dehydration in an 
ascending series of ethanol aqueous solutions (50%-100%) at room temperature. The 
samples were freeze-dried and then sputter coated with platinum for SEM observation. 
Attached Energy Dispersive X-Ray Analysis (EDX) was carried out to analyze the 
elementary composition of the scaffolds to confirm the presence of collagen.  
 
3.2.7 Statistical analysis 
 
 The collagenase degradation and cell proliferation were performed in triplicate and 
expressed as mean ± standard deviation (SD). Student’s t-test was employed to assess 
statistical significant difference of the results. Difference was considered statistically 
significant at p<0.05. 
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3.3 Results and discussion  
 
3.3.1 Surface morphology of collagen nanofibers before and after 
crosslinking 
 
 Type I collagen derived from calf skin was electrospun to form highly uniform 
collagen nanofibers shown in Figure 3.2a. The electrospun collagen (COLL) exhibited 
a non-woven and highly porous and nanofibrous structure with few observable defects 
or beads. Collagen nanofibers had a relatively uniform diameter of approximately 300-
400 nm. The diameter of the electrospun nanofibers (size and distribution) can be 
regulated by varying the concentration of collagen, the spinning voltage, and the 
distance between the syringe and the plate collector. The thickness of the collagen 
scaffold can be increased by simply increasing the electrospinning time and/or amount 
of collagen.  
 
 The morphology of the collagen nanofibers after the various crosslinking 
treatments was shown in Figures 3.2b-f. The aqueous crosslinked collagen scaffolds 
(Figure 3.2b) exhibited a denser structure and its porosity decreased dramatically. 
Besides, the nanofibers were flattened and distorted compared with the clear fiber 
structure on COLL (Figure 3.2a). This substantial morphology change after aqueous 
crosslinking can be attributed to the fast degradation and swelling of the fibers in 
aqueous media at the early stage of reaction when the resistance of collagen nanofibers 
to degradation was weak. The collagen nanofibers easily degraded and swelled, and 
the nanofibrous architecture may collapse severely.  
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Figure 3.2 SEM micrographs of collagen nanofibers before and after different 
crosslinking treatment, (a) COLL, (b) GTA solution, (c) UV, 30min, (d) DHT100, 2 
days, (e) DHT200, 30min, (f) GTA vapor, DHT100: DHT treatment at 100oC, 
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 At the high magnification of FESEM, the surface of the aqueous crosslinked 
collagen nanofibers (Figure 3.3a) were found to be eroded partially and the spaces 
among the fibers were covered with degraded collagen clots as marked by the two 
arrows in the figure. Therefore, aqueous crosslinking was found to reduce the porosity 
and nano-dimension of the collagen matrix. High degradation on the nanofibers made 
of natural gelatin in aqueous solution was also reported in the another study [207], in 
which the nanofibrous structure was destroyed by a drop of water. The resistance of 
collagen to aqueous degradation seemed to be higher than the gelatin nanofibers due to 
its unique triple-helix structure and crosslinkage between collagen molecules, 
Nonetheless, the degradation rate of collagen with aqueous GTA solution treatment is 
still high, and thus GTA vapor crosslinking method was subsequently used.  
 
 Rather than using aqueous crosslinking, three non-aqueous crosslinking systems, 
UV irradiation, DHT, and GTA vapor, were chosen for crosslinking electrospun 
collagen nanofibers to avoid the fiber erosion. Compared with the aqueous crosslinked 
scaffold (Figure 3.2b), all the non-aqueous crosslinked scaffolds (UV, DHT and GTA 
vapor) maintained their high porosity and nanofibrous morphology (Figures 3.2c-f). 
These nanofibers also became slightly denser because the fibers may have shrunk 
when exposed to heating and UV irradiation. For GTA vapor crosslinked collagen, 
glycine solution washing after crosslinking was needed to remove the cytotoxic 
residual GTA. This aqueous washing may make the scaffolds slightly more compact 
than the scaffolds from the other two crosslinking methods due to the swelling of the 
collagen nanofibers in aqueous media. The severe fiber erosion as observed in aqueous 
crosslinking (Figure 3.2b) was avoided and the nano-dimension and porous structure 
of the collagen nanofibers were preserved.  
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Figure 3.3 FESEM micrographs of the crosslinked electrospun collagen nanofibers, (a) 
GTA solution, (b) DHT100, 2days, (c) DHT200, 30min. 
 
 
 It is well-known that electrospun nanofibers form a nonwoven structure by the 
overlaying of random oriented fibers during electrospinning, which generally lacks 
sufficient interfiber bonding between fibers [208]. This loose structural scaffold may 
result in relatively low mechanical strength. The two different DHT treatments at 
100°C and 200°C (DHT100 and DHT200) were compared to investigate the effect of 
temperature on the formation of interfiber bonding. The DHT treatment has been 
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collagen chains to increase the strength and biostability of fibrillar collagen [92, 209]. 
However, DHT treatment at low temperature (≤100oC) has been reported to be a weak 
crosslinking [198, 202] and the resultant collagen scaffolds were still easily degradable. 
Hence the DHT treatment at approximately 200°C was attempted in this study in order 
to provide a more efficient crosslinking and to form stronger interfiber bonding as 
stated in the literatures [208, 210]. As shown in Figure 3.3b, the DHT100 nanofibers 
exhibited less interfiber bonding compared with the DHT200 nanofibers (Figure 3.3c) 
where the fibers were molten to some degree and interfiber bondings were formed. 
Thus, the high temperature DHT treatment not only can form intermolecular 
crosslinking, but also result in interfiber linkages. Longer heating time at 200°C or 
even instant exposure at higher temperature above 200°C may lead to severe melting 
or even burning of collagen nanofibers. Dried electrospun collagen nanofibers had a 
melting temperature of slight above 200°C as confirmed by our DSC results (data not 
shown). At high temperature DHT treatment, N2 environment during vacuum release 
was important to avoid the oxidation of collagen, which may severely damage collagen 
and make it highly susceptible to proteolytic degradation [211].  
 
3.3.2 Collagenase digestion  
 
 As shown in Figure 3.4, after exposing to collagenase digestion, all crosslinking 
treated collagen remarkably resisted degradation. 93% of the uncrosslinked collagen 
(COLL) was dissolved after 5 days of collagenase incubation. The UV crosslinked 
collagen exhibited relatively low degradation in the early incubation period (1 day), 
but had higher degradation after 3 days of incubation than the other methods. This 
suggests that UV irradiation might produce non-uniform crosslinking and the 
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crosslinking reaction was most likely initiated on the surface of collagen nanofibers 
upon exposure to UV, and crosslinking at the core of the fibers could be hindered due 
to the limited UV transmission. DHT100 was found to be a relatively weak 



















Figure 3.4 The amount of the noncrosslinked and crosslinked collagen scaffolds 
digested by collagenase solution, the amount digested was presented as percentage of 
the original dry weight of the collagen samples. (#) p<0.05 compared with UV; (*) 
p<0.05 compared with DHT100.  
 
 Both DHT200 and GTA vapor crosslinked collagen exhibited a similar and gradual 
degradation to collagenase digestion and were most stable compared with other 
samples. Therefore, both DHT200 and GTA vapor can be effective crosslinking 
methods for collagen nanofibers. The higher biostability of DHT200 is likely due to 
the high degree of crosslinking which were not achieved at DHT100.  
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 Proliferation of human conjunctiva fibroblasts (RCFs) on the crosslinked 
electrospun collagen scaffolds were analyzed by MTT assay. The noncrosslinked 
scaffolds (COLL) were used as a control. Figure 3.5 shows that cell proliferation 
increased on all of the scaffolds from day 2 to 7. This suggests that the high bioactivity 
of the collagen scaffolds coupled with the high surface area and high porosity formed 













Figure 3.5 Cell proliferation on the collagen scaffolds. (#) p<0.05 compared with 
DHT100. 
 
 Only slightly higher cell proliferation on the crosslinked scaffolds was observed 
compared with the noncrosslinked scaffolds after 2 days. After 7 days incubation, 
however, substantial increase in cell proliferation was found on the crosslinked 
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biostability of the scaffolds and provided a better physical support for cell proliferation. 
At the early incubation stage, the noncrosslinked collagen was not degraded 
completely and their function as a physical and biological support still remained. At 
the longer time, the more biostable collagen might provide better culture environment 
for cell growth. Among all crosslinked scaffolds, DHT200 and GTA vapor crosslinked 
collagen exhibited the highest cell proliferation after 7 days incubation. This is likely 
due to the higher biostability of DHT200 and GTA shown from the collagenase 
digestion test.  
 
 Figure 3.6 contains SEM micrographs of HCFs seeded on all the five groups of 
collagen scaffolds after 3 days in culture. HCFs showed typical fibroblastic 
morphology with flattening and polygonal extensions. Only integral nanofibrous 
morphology was observed on DHT200 and GTA vapor crosslinked scaffolds (Figures 
3.6d-e), while the three other scaffolds were degraded to different degree and their 
nanofibrous morphology were not observed (Figures 3.6a-c). The two relatively weak 
crosslinked scaffolds (UV and DHT100) exhibited smooth surface morphology and 
their presence of collagen can not be observed from the SEM image.  
 
 From EDX analysis in Table 3.1, however, a higher ratio of carbon and nitrogen on 
the two crosslinked scaffolds was found compared with COLL, while the significant 
lower ratio of carbon and nitrogen on COLL was found to be as low as the ratio found 
on a glass substrate. Carbon and nitrogen are main two important elements of collagen 
and the results indicate that DHT 100 and UV crosslinked collagen were still present in 
the sample while the noncrosslinked collagen was totally degraded without any 
collagen component left, and the surface of the glass coverslip was totally exposed for 
the test. 
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Figure 3.6 SEM micrographs of HCFs seeded on the scaffolds scaffolds after 3 days, (a) 
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COLL 33.4 6.1 
UV  47.5 11.2 
DHT100 52.7 12.5 
DHT200 53.4 16.3 
GTA  54.6 15.4 
 
a The composition was determined by EDX on the surface space free of cells on the 
scaffolds as shown in Figure 3.6, glass cover slip: Glass cover: C 22.1%; N 4.0%; 
initial collagen nanofibers: C 60%; N 17%. 
 
Chapter 3 
   64
3.4 Conclusions 
 
 This chapter described the crosslinking and characterization of electrospun 
collagen nanofibers with respect to morphology observation, biostability and 
biological properties. This work showed that the three non-aqueous crosslinking 
methods enhanced the biostability of the electrospun collagen nanofibers, and its nano-
dimension and porous structure was preserved after crosslinking. UV irradiation and 
DHT treatment at 100°C were found to produce relatively weak crosslinking, and the 
increase in biostability was limited. DHT treatment at 200°C and GTA vapor 
crosslinking could provide higher crosslinking degree and their scaffolds exhibited a 
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Chapter 4 
 
Formation of collagen-GAG blend nanofibrous scaffolds 




 Proteins of the extracellular matrix (ECM) such as the collagens and the 
glycosaminoglycans (GAGs) are among the most abundant in the body. Collagen type 
I, the most abundant protein is a fibrillar protein with a long and stiff triple helix 
structure which provides mechanical and physical support of tissues [53]. GAGs are 
glycoproteins with a protein core and polysaccharide branches composed of repeating 
disaccharide units containing carboxylic and/or sulfate ester groups [212]. These 
functional groups bridge and link collagens to construct interpenetrating networks of 
ECM, which maintains and defines the shapes of tissue and organs, especially in 
connective tissue [196].  
 
 Collagen and GAGs, as constituents of native tissues, are widely utilized to 
fabricate scaffolds serving as active analogs of native ECM. Collagen-GAG scaffolds 
have been used extensively for in vitro studies of cell-ECM interactions and as a 
platform for tissue biosynthesis including in vivo studies of induced tissue or organ 
regeneration [130, 139, 213, 214]. Favorable characteristics of scaffolds from these 
natural materials encourage host cells to repopulate and format new tissues that closely 
simulate the native organization [215-217]. Additionally, they enhance biological 
interactions with cells and speed up tissue regeneration by introducing cell-specific 
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ligands or extracellular signaling molecules, such as peptides and oligosaccharides 
[218]. Blending collagen and GAG is to leverage the unique advantageous properties 
of the two components and offset the limitations of individual materials. Collagen is 
the main component of ECM in natural components. GAG has been found to be an 
important factor influencing contraction, ECM synthesis, and transparency of matrix in 
the developing cornea by controlling the regular arrangement of the collagen fibrils 
and cellular components in the stroma [70, 175]. The combination of collagen and 
GAG is unique in skin regeneration since collagen or GAG alone can not heal full 
thickness wounds [219-221]. GAG has also been reported to increase the use of 
collagen as a biomaterial and to affect cellular response, morphology and stiffness of 
the resultant matrix [196, 222, 223]. In addition, attachment of GAG to collagen 
provides the opportunity to study the biocharacteristics of these polysaccharides [195].  
 
 Collagen-GAG scaffolds in gel or sponge form have been extensively 
manufactured as constructs with high porosity, high surface area and specific three 
dimensional shape for tissue engineering applications [221, 224]. However, these 
traditional scaffolds exhibit poor mechanical properties and unacceptable physical 
structure for many specific organ or tissue regeneration scaffolds [16, 114]. This is due 
at least in part to the great differences existing between native ECM and these 
manufactured scaffolds. In native connective tissue, the collagen structure is organized 
in a three-dimensional network of nano-scale diameter fibers [225]. Stronger 
interaction between cells and fibers has been reported when the fiber diameters is 
smaller than the size of the cells. Traditional collagen gels can self-assemble into a 
nano-scale fiber-like superstructure [226], but their application is limited due to the 
poor physical strength. Collagen sponges manufactured by freeze-drying are 
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mechanically stronger, but they only possess a microporous structure with a magnitude 
larger than the nano-scale fibrillar network of native ECM [57].  
 
 The potential for applying nano-scale or micro-scale scaffolds in tissue engineering 
is significant as it is believed that the nano-scale dimension provides a well-defined 
architecture with high surface area to volume ratio, which may promote tissue 
biosynthesis, guide cell growth, and speed up subsequent tissue regeneration when 
compared with any other known forms of gels or sponges [131, 132, 227]. 
Electrospinning is a very useful technique of producing polymeric nanofibers by 
applying electrostatic forces to draw a positively charged polymer solution into a fine 
nano-scale filament [125]. Electrospun nanofibrous scaffolds of natural or synthetic 
polymers with a non-woven, porous, three-dimensional structure have been applied in 
tissue engineering exhibiting excellent cell adhesion and proliferation [133]. An 
appropriate solvent system is a crucial factor for the successful electrospinning of 
nanofibers especially for blended composites. Solvent characteristics suitable for 
electrospinning are not well studied in many polymer systems, although it is widely 
accepted that solvents with high dielectric value or good conductivity are good choices 
for electrospinning. The parameters for electrospinning and the process have been 
documented in details in many studies [228-231].  
 
 In this chapter, we adopted electrospinning to fabricate a novel nanofibrous 
collagen-GAG scaffold based on collagen and chondroitin sulfate (CS), a common 
GAG. A mixture of trifluoroethanol (TFE) and water was used as the solvent to 
dissolve blended collagen and CS to obtain a homogeneous solution with suitable 
viscosity for electrospinning. The resultant nanofibrous collagen-GAG scaffolds were 
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crosslinked by GTA vapor. The in vitro biocompatibility of the scaffolds was 
evaluated using rabbit conjunctiva fibroblasts (RCF) in cell culture.  
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 All chemicals and reagents were purchased from Sigma-Aldrich unless specified 
separately. Main chemicals and reagents used in this study included calf skin type I 
collagen, chondroitin-6-sulfate (CS) sodium salt from bovine trachea, 2,2,2-
trifluoroethanol (TFE, Fluka), GTA, glycine (Alfa Aesar), 3-(4,5-dimethylazol-2-yl)-
2,5-diphenyl-2H-tetrazolium bromide (MTT), type I collagenase from clostridium 
histolyticum, micro BCATM protein assay kit (Pierce), Dulbecco’s modified eagle’s 
medium (DMEM, Gibco), and fetal bovine serum (FBS, Hyclone).  
 
4.2.3 Preparation of nanofibrous collagen-GAG scaffolds 
 
 The electrospinning of the blended collagen-GAG nanofibers has not been reported 
in the literature, so a suitable solvent was to be established first. In the preparation of 
conventional collagen based scaffolds, collagen is commonly dissolved in acetic acid 
first. However, attempts to electrospin collagen nanofibers using such a solution failed 
and only drops of collagen solution were ejected from the tip of the syringe needle. 
Previous studies of collagen electrospinning used 1,1,1,3,3,3 hexafluoro-2-propanol 
(HFP) as the solvent [185, 232], but unfortunately the solubility of CS in HFP was 
found to be very low. Hydrochloric acid, which is used in making blended collagen-
polyethylene oxide nanofibers [233], was also not suitable for CS. By taking the 
hydrophilic nature of CS into consideration, a mixed solvent system based on different 
ratios of water and TFE was finally adopted for the electrospinning of blended 
collagen-GAG nanofibers. Collagen solutions with 4 to 10 wt% CS were prepared in 
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this mixed TFE/water solvent at various volumetric ratios (4:1 to 3:2) under magnetic 
stirring for 24 h at room temperature. The final concentration of total collagen-GAG 
ranged from 10 to 20 wt%.  
 
 An electrospinning apparatus as documented in Figure 2.4 was used to fabricate 
collagen-GAG nanofibers as scaffolds. During electrospinning, the solution was placed 
into a 3 ml syringe fitted to a 27½ G needle. A syringe pump was used to feed the 
solution into the needle tip at a feed rate of 0.5-1.5 ml/h. A voltage of 10-20 kV 
provided by a high voltage power was applied between the needle (anode) and the 
grounded collector (cathode) with the distance of 15-20 cm. The solution flew in the 
form of a charged jet toward the collector. As the solvent evaporated, the solidified 
nanofibers were collected on 15 mm diameter glass coverslips sitting on the collector. 
Finally the constructs were placed under vacuum overnight for the removal of residual 
solvent. Pure collagen nanofibers as a control also were fabricated by electrospinning 
with HFP as described previously [185]. TFE was not used for pure collagen 
electrospinning because it caused more bead formation during electrospinning than 
HFP. 
 
4.2.4 Crosslinking of collagen-GAG scaffolds 
 
 The electrospun collagen based scaffolds were exposed to saturated GTA vapor at 
room temperature for 2 days for crosslinking as GTA vapor was found to be effective 
crosslinking method in Chapter 3. Briefly, scaffolds were placed on a ceramic grid 
inside a glass desiccator containing an aqueous GTA solution (15 v/v%). Excess GTA 
vapor were purged periodically to avoid vapor condensation, which may lead to fiber 
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erosion and scaffold distortion. After crosslinking, the scaffolds were put in 0.02 M 
glycine aqueous solution for 4 h to quench unreacted GTA and finally rinsed in 
deionized water for 4 times, dried under vacuum and stored in a desiccator until use. 
 
4.2.5 Characterization of collagen-GAG scaffolds 
 
 Fiber morphology of the noncrosslinked and crosslinked scaffolds was visualized 
and compared using a JEOL 6320 scanning electron microscope. Platinum was sputter 
coated onto the surface of the samples before SEM observation. The SEM was 
performed at an accelerating voltage of 15 kV. The diameters of the fibers were 
measured from SEM images with a custom code image analysis program (Image J; 
National Institutes of Health).  
 
 The surface elemental composition of the collagen/GAG scaffolds was determined 
by X-ray photoelectron spectroscopy (XPS). Pure CS, initial collagen-GAG scaffold 
(COLL-CS-04), and pure collagen scaffold were measured by XPS analysis. To 
confirm the presence of CS in the collagen scaffold in aqueous environment, another 
COLL-CS-04 sample was incubated in PBS at 37oC for 2 days (COLL-CS-04-II) 
before the surface analysis. The XPS measurement was performed on an AXIS His 
spectrometer (Kratos Analytical Ltd., Manchester, England).  
 
4.2.6 Enzymatic stability of nanofibrous collagen-GAG scaffolds 
 
 In vitro degradation of the above scaffolds was performed by incubating the 
scaffolds in collagenase solution similarly as described in Section 3.2.5 of chapter 3. 
Collagen samples were incubated in collagenase solution for 1 day, 3 days and 6 days.  
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4.2.7 In vitro evaluation with rabbit conjunctiva fibroblasts 
 
4.2.7.1 Cell isolation and culture conditions 
 Rabbit conjunctiva fibroblasts (RCFs) were cultured from rabbit conjunctiva at the 
Singapore Eye Research Institute. Fibroblasts from rabbit conjunctiva were obtained 
from the freshly dissected tissue following their migration from tissue incubated in 
tissue culture plates with medium consisting of DMEM supplemented with 10% fetal 
bovine serum, 1 mM L-glutamine, and 100 U/ml penicillin at 37 oC and 5% CO2. The 
medium was replaced every two days. When the cells grew to 80% confluence, the 
cells were harvested and subcultured by trypsin treatment. The cells used for in vitro 
testing in the study were between passage 2 and 5.  
 
4.2.7.2 Cell culture  
 Cell culture conditions, the standard MTT assay, and SEM observation were 
performed similar as described in Section 3.2.6.2 of Chapter 3. RCFs were seeded into 
the wells at a density of 104 cells/well. The MTT assay was analyzed after 3 days and 7 
days incubation. The SEM observation was performed after 7 days incubation. 
 
4.2.8 Statistical analysis 
 The collagenase degradation and cell proliferation were analyzed using Student’s t-
test to assess statistical significant difference of the results as described in Section 
3.2.7 of Chapter 3. Difference was considered statistically significant at p<0.05. 
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4.3 Results and discussion 
4.3.1 Electrospinning and characterization of collagen-GAG nanofibers 
 
 In order to obtain electrospun collagen-GAG nanofibers for scaffolding, different 
solvent systems and solution properties (concentration and the ratio of collagen/CS) 
were examined. With the mixed TFE/water solvent system, we succeeded in forming a 
blended CS and collagen nanofibers. To achieve the fine nanofibrous structure with 
few beads, each ratio of CS and collagen required a specific proportion of water and 
TFE, although CS only accounted for a small quantity in the blended solution. In 










Figure 4.1 SEM micrographs for electrospun collagen-GAG scaffolds, (a) COLL-CS-
4-collagen and 4% CS; the spinning solution concentration = 180 mg/ml; TFE:water = 
4:1; (b) COLL-CS-10-collagen and 4% CS; the spinning solution concentration = 120 
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 After several attempts, it was found that forming a blend of 96% (w/w) collagen 
and 4% (w/w) CS electrospun fibers (COLL-CS-04) required 4:1 (v/v) ratio of TFE to 
water. Figure 4.1a shows the SEM micrograph of a typical non-woven COLL-CS-04 
scaffold using the above mentioned mixed solvent. The combined concentration of 
collagen and CS in the solution was 18 wt%. When the percentage of CS in the 
blended fibers increased to 10% (w/w) (COLL-CS-10), the 4:1 ratio of TFE/water 
solvent failed and the precipitation of CS was observed. To overcome this problem, 3:2 
ratio of TFE to water was adopted. Figure 4.1b shows the SEM micrograph of the 
COLL-CS-10 scaffold with the combined collagen and CS concentration of 12 wt%. 
Both scaffolds shown in Figure 4.1 exhibited large interconnected voids formed by the 
deposition of randomly arrayed fibers. The diameters of the collagen-GAG fibers were 
in the range of 100 to 600 nm, which coincided with size of collagen fibers found in 
natural ECM [234]. COLL-CS-04 exhibited more uniform nanofibers with the mean 
diameter of 260 nm. COLL-CS-10 possessed a smaller mean diameter (180 nm), but 
had a broader diameter distribution. It is known that the solution concentration is a key 
factor determining nanofiber diameter since it affects the solution viscosity. Higher 
concentration, and hence higher viscosity, in electrospinning results in the formation of 
fibers with larger diameters [125, 230]. This may explain the larger mean diameter 
found in COLL-CS-04 (18 wt% concentration) compared with COLL-CS-10 (12 wt% 
concentration). Moreover, since CS is a salt, its addition may lead to a higher charge 
density on the surface of the electrospinning jet, inducing higher electrostatic force and 
resulting in the formation of the fiber with smaller diameter [230]. It was also reported 
that higher charge density may cause fibers to repel each other during the spraying of 
the fibers and big fibers split into smaller ones to form a spider web-like network [235]. 
This may further explain the spider web structure found in COLL-CS-10. Bead 
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formation and desultory morphology were also observed on COLL-CS-10, which was 
likely due to the low viscosity (from the low solution concentration), an important 
factor determining the formation of beads/continuous fibers. Since COLL-CS-04 
showed a better fiber architecture and its fiber dimension also was closer to that found 
in native form in many tissues such as the cornea [178], the subsequent biostability and 
in vitro testing were only conducted with the COLL-CS-04 scaffold. To maintain the 
matrix or scaffold function during implantation, crosslinking of collagen is necessary 
to maintain the structural integrity of the scaffold before cells repopulate and new 











Figure 4.2 SEM micrograph of the crosslinked collagen-GAG scaffold by GTA vapor. 
 
 
 Crosslinking in aqueous media, however, may erode the collagen nanofibers at 
initial crosslinking and alter the desirable nano-scale dimension of the fibers. Thus, 
crosslinking by GTA vapor was performed in this study to keep integrity of the 
nanofibers. As shown in Figure 4.2, the fibrillar morphology of nanofibers swelled and 
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this was most likely due to hydration since a 15% GTA aqueous solution was used to 
produce saturated GTA vapor for crosslinking. In addition, the interconnected voids or 
pores were preserved in the crosslinked scaffold. This porosity may play a significant 
role on the transport of nutrients particularly glucose and even cell migration during 
tissue regeneration.   
 
4.3.2 Collagenase degradation 
 
 The collagenase digestion assay provides quantitative data on collagen resistance 
against enzyme degradation. As shown in Figure 4.3, the crosslinked collagen 
nanofibrous scaffolds with or without CS (X-COLL and X-COLL-CS-04) exhibited a 
significantly lower collagenase degradation at any time point compared with the 
noncrosslinked fibers (COLL and COLL-CS-04) (p<0.05). 90% of the noncrosslinked 
fibers were digested after 3 days collagenase incubation, but only 35% of the 
crosslinked fibers were digested even after 6 days incubation. Therefore, crosslinking 
significantly increased the resistance of collagen against collagenase degradation.  
 
 Both COLL and COLL-CS-04 exhibited a similar degree of degradation as well as 
both X-COLL and X-COLL-CS-04, which suggests that the addition of CS did not 
improve the resistance of collagen against collagenase degradation. The likely reason 
is that simple physical blending or mixing of GAG and collagen solution failed to form 
uniform arrangement of GAG in collagen nanofibers. This arrangement of GAG was 

















Figure 4.3 Degradation of collagen-GAG scaffolds by collagenase, COLL: 
noncrosslinked collagen; COLL-CS-04: noncrosslinked collagen-GAG; X-COLL: 
crosslinked collagen; X-COLL-CS-04: crosslinked collagen-GAG. Mean for n=3 ±SD. 
(*) p<0.05 compared with COLL-CS-04 for the same digestion period; (#) p<0.05 
compared with COLL for the same digestion period. 
 
 
 After collagenase digestion for 1 day, the structure of collagen-GAG nanofibers 
was observed by SEM (Figure 4.4). The interconnected void structure in the 
noncrosslinked scaffold was completely degraded and pillar-like struts with beads that 
were significantly bigger than the nanofibers were observed.  This structure may be the 
result of aggregation and gelatinization of the degraded collagen deposited on some 
undegraded nanofibers. In contrast, a better structural integrity was maintained on the 
crosslinked collagen-GAG nanofibers than on the noncrosslinked ones, though the 
porous structure of the crosslinked collagen-GAG fibers was reduced to some degree 
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noncrosslinked collagen-GAG scaffold was more susceptible to enzymatic degradation 










Figure 4.4 SEM micrographs of noncrosslinked and crosslinked collagen-GAG 
scaffolds after 1 day of collagenase digestion, (a) COLL-CS-04, (b) X-COLL-CS-04. 
 
 
4.3.3 XPS analysis  
 
 The elemental composition and wide scan spectra of the scaffolds were determined 
by XPS as shown in Table 4.1. Pure collagen (COLL) exhibited higher nitrogen 
(14.22%) and lower sulfate (0.14%) compared with pure CS (1.38% and 3.96% 
respectively). In comparison with COLL, a decreased nitrogen ratio (10.65%) and 
increased sulfate ratio (0.37%) were observed in COLL-CS-04 due to the presence of 
CS. A similar elemental composition in both COLL-CS-04 and COLL-CS-04-II (the 
spectrum not shown) indicates that the buffer incubation did not change the surface 
composition of the scaffolds and suggests that CS was not released from the scaffold 
and fiber structure was intact when exposed to cell culture environment.  
a b
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Table 4.1 Elemental composition of the samples determined by XPS. 
 
Composition (%) Samplea 
C N O S 
COLL 56.49 14.22 29.05 0.14 
COLL-CS-04 63.55 10.69 25.38 0.37 
COLL-CS-04-II 63.52 10.56 25.53 0.38 
CS 53.98 1.38 40.68 3.96 
 
a COLL: pure collagen scaffold; COLL-CS-04: collagen-4%CS scaffold; COLL-CS-
04-II: COLL-CS-04 incubated in PBS solution for 2 days; CS: pure CS sample. 
 
4.3.4 Cell culture in vitro 
 
 Proliferation of rabbit conjunctiva fibroblasts (RCF) on the electrospun collagen-
GAG scaffolds was analyzed by MTT assay. Scaffolds with noncrosslinked collagen 
fibers (COLL) were used as a control at 3 days incubation. As shown in Figure 4.5, the 
cell proliferation increased on all scaffolds from day 3 to 7. It suggested that the 
nanofibrous collagen scaffold supports the growth of RCF. The high surface-to-volume 
ratio is believed to enhance cell adhesion and proliferation [185, 237]. After 7 days of 
culture, the crosslinked scaffolds (X-COLL and X-COLL-CS-04) exhibited higher cell 
proliferation compared with the noncrosslinked scaffolds (COLL and COLL-CS-04) 
respectively (p<0.05). This can be attributed to the fact that crosslinking increased the 
biostability of the scaffolds and provided a better physical support for cell proliferation. 
These also indicates that GTA vapor crosslinking of the collagen scaffold did not 
induce any observable toxicity and not inhibit cell proliferation, which was most likely 
due to the thorough glycine quenching and washing steps followed immediately after 
the GTA vapor crosslinking. For X-COLL-CS-04, the incorporation of CS also 
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significantly promoted cell proliferation in comparison with the collagen scaffolds 
without CS (COLL and X-COLL) (p<0.05). The presence of CS in collagen scaffolds 
may stimulate the growth of RCF since it has been reported that the growth factors and 












Figure 4.5 Cell proliferation on the collagen/GAG scaffolds, COLL: noncrosslinked 
collagen scaffold; X-COLL: crosslinked collagen scaffold; COLL-CS-04: 
noncrosslinked collagen-GAG scaffold; X-COLL-CS-04: crosslinked collagen-GAG 
scaffold. Mean for n=3 ±SD. (*) p<0.05 compared with COLL, COLL-CS-04, or X-
COLL after 7 days of culture; (#) p<0.05 compared with COLL after 7 days of culture. 
 
 
 Cell morphology on the collagen-GAG scaffolds was studied by SEM after 7 days 
cell culture. As shown in Figure 4.6, on the crosslinked and noncrosslinked collagen-
GAG scaffolds (COLL-CS-4 and X-COLL-CS-04), RCF showed typical fibroblastic 
morphology with flattening and polygonal extensions. At higher magnification, 
fibroblastic tethering on the surface of the nanofibers was also evidenced in X-COLL-
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between cells and the nanofibrous collagen-GAG scaffolds. Furthermore, a less dense 
structure with voids (labeled as “V”) were observed on the noncrosslinked collagen-
GAG scaffold (COLL-CS-04, Figure 4.6c), while the intact structure was found on the 
crosslinked collagen-GAG one (X-COLL-CS-04, Figure 4.6d). These voids were 
likely formed by the degradation and breakage of the fibers during cell culture, 
reflecting the weak mechanical strength of the noncrosslinked scaffold upon 
biodegradation. In contrast, the intact structure of X-COLL-CS-04 indicates that 















































Figure 4.6 SEM micrographs of RCFs on the collagen-GAG scaffolds after 7 days 
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4.4 Conclusions 
 
 The potential for tissue engineering using collagen-GAG scaffolds is huge as both 
collagen and GAG are important components of ECM providing bioactive and 
physical properties for cell growth or tissue regeneration. In this chapter, a novel 
nanofibrous collagen-GAG scaffold was constructed by electrospinning using a 
mixture of TFE and water as the dissolving solvent. Under optimum condition, the 
electrospun collagen-GAG scaffold exhibited a uniform nanofibrous and porous 
structure with a mean diameter of 260 nm, which is similar to that found in native 
ECM. The scaffolds after crosslinking exhibited a high biostability from the collagen 
digestion test. Its excellent biocompatibility with RCF was demonstrated by a standard 
cell proliferation assay and cell morphology studies at the nano-level. The potential of 
applying the nano-scale collagen-GAG scaffolds in tissue engineering is significant 
since this nano-dimensional scaffold made of natural ECM mimics closely native ECM 
found in our body and may eventually support more active tissue regeneration. The 
specific and regular arrangement of the ECM may play a specific role in some specific 
tissue regeneration. Our study suggests that further design or controlling of 
electrospinning technique is needed to prepare specific and complex scaffolds as 
needed for corneal reconstruction.  
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Chapter 5 
 
Aligned architecture of electrospun collagen scaffolds for 
in vitro application 
 
5.1 Introduction  
 
Considerable effort has been dedicated to develop biodegradable scaffolds which 
are suitable for tissue engineering applications [23, 27, 45]. An ideal scaffold should 
mimic the structural and functional properties of the native extracellular matrices 
(ECMs). In order to maximize cell-scaffold interactions and to achieve native type 
cellular response, these synthetic ECMs or scaffolds must be designed to possess 
suitable biological and structural properties [26, 39, 133]. The scaffolds should support 
normal cell growth and differentiation while maintaining three-dimensional 
architecture for tissue regeneration. Besides, either in vitro or in vivo applications, the 
scaffolds should either eventually be degraded and resorbed or incorporated into the 
newly generated tissue [23, 29, 239]. Therefore, an essential property of the scaffold is 
to provide good interaction or communication between individual cells and their 
immediate surroundings [43, 240]. 
 
 Electrospinning is a well known and ubiquitous technique to produce nanofibers 
and has been used by many researchers to make nanofibrous matrix for tissue 
engineering applications [126, 133, 187, 232, 241, 242]. Most of the nanofibers 
produced by electrospinning were collected into a nonwoven web form. This 
nonwoven web, which contains very fine fibers, generally has random orientation and 
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poor mechanical properties. However, most native ECMs found in tissues or organs 
have regular or defined orientation architecture, which is significant for tissue function. 
Therefore, a well-defined architecture is believed to be required to precisely mimic the 
native ECM for guiding cell growth or tissue regeneration [114, 225]. In tissue 
engineering, integration of nanofibers into specific orientations to mimic the structure 
of native tissue maybe very useful for certain applications, such as for skin or blood 
vessels [114]. Therefore, a well-defined architecture is believed to be required to 
precisely mimic the native ECM for guiding cell growth or tissue regeneration [114, 
225]. Its success in controlling the alignment within nanopatterning of scaffolds has 
been achieved by many approaches during electrospinning. The use of aligned 
synthetic polymer nanofibers in tissue engineering has been shown to control cell 
orientation [114, 190]. However, synthetic polymers usually exhibit low 
biocompatibility due to the presence of non-native components that induce adverse 
responses from our body. Besides, the study on how aligned fibers affect in vitro 
culture and the related knowledge is still incomplete. Most reports are only focused on 
synthetic polymers since the electrospinning of synthetic polymers is relatively easy, 
though natural polymers are preferable in term of biocompatibility.  
 
Native ECMs, which are primarily composed of collagens, are typically fibrillar 
structures with various nano-sized diameters and regular network arrangements [26, 43, 
175]. This architecture of collagen fibers within natural ECM will be reproduced by 
controlled alignment of the available fabrication techniques since it might be critical to 
the artificial scaffolds ability to influence regulatory cell-matrix interaction and impart 
high mechanical strength. The current challenge facing the researchers is controlling 
the specific orientation or alignment of the fibers during electrospinning of natural 
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polymers. In this chapter, our goal is to develop an aligned nanofibrous scaffold to 
mimic the native corneal stroma, which is composed of aligned collagen fibers. This 
organization is thought to be a criterion of preserving toughness and transparency of 
corneas. This type of scaffold is found to closely mimic the native ECM in term of 
component and physical structure due to its natural origin and nanofibrous dimension.  
 
In the chapter, the aligned nanofibrous collagen, one common ECM structure in 
native tissue, was used to evaluate the effect of alignment on cell orientation and the 
cell-scaffold interaction. Our previous research found that noncrosslinked collagen 
nanofibers were physically unstable for in vitro applications due to their high 
degradability. GTA crosslinking was found to significantly increase the biostability of 
the collagen scaffolds with minimal toxicity. Thus, all the collagen scaffolds used for 
the in vitro culture were crosslinked. Noncrosslinked collagen scaffolds were not used 
for in vitro study, though they were used for surface characterization.  
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5.2 Materials and Methods  
5.2.1 Materials 
 
 All chemicals and reagents used in this study were purchased from Sigma-Aldrich 
unless specified separately. Main chemicals and reagents included: calf skin type I 
collagen, 1,1,3,3,3 hexafluoro-2-propanol (HFP), GTA, glycine (Alfa Aesar), 3-(4,5-
dimethylazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide (MTT), Dulbecco’s modified 
eagle’s medium (DMEM, Gibco), and fetal bovine serum (FBS, Hyclone).  
 
5.2.2 Preparation of aligned collagen nanofibrous scaffolds 
 
 A schematic of aligning electrospun nanofibers using a rotating wheel collector 
with a 20 cm diameter is shown in Figure 5.1. Type I collagen was first dissolved in 
HFP at a concentration of 80 mg/ml and the collagen suspension was placed into a 3 
ml syringe fitted to a 27½G needle. A syringe pump was used to feed the collagen 
solution into the needle tip at a feed rate of 1.0 ml/h. A voltage of 15 kV was applied 
across the solution and the collector, and the distance between the needle and the 
collector was 15 cm. As the fibers approaching from the syringe to the rotating wheel, 
electrostatic attraction drew the fibers to 15 mm diameter glass coverslips attached on 
the sharp edge of the wheel. The fibers were deposited and aligned along the rotating 
direction due to the continuous rotating motion of the wheel. The linear velocity of the 
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 Random collagen nanofibers as a control were also prepared on the coverslips that 
were put on a non-moving metal collector plate using the similar processing 
parameters described above. The scaffolds were dried overnight to remove residual 
solvents under vacuum at room temperature. The collagen scaffolds were crosslinked 
in 30% GTA vapor for 48 hr at room temperature, soaked in a 0.02 M glycine aqueous 
solution to quench unreacted GTA, and finally rinsed in deionized water for 4 times. 




















   89
 
5.2.3 Surface characterization 
 
 The morphology of aligned and random collagen nanofibrous scaffolds 
(with/without crosslinking) was observed using scanning electron microscope (SEM, 
JEOL 6320 electron microscope) at an accelerated voltage of 15kV. The diameters of 
the fibers were measured from SEM images with a custom code image analysis 
program (Image J; National Institutes of Health). Platinum was sputtered onto the 
surface of the samples before SEM scanning. Fiber orientation was analyzed by 
measuring the individual orientation and angular deviation (AD) of the fibers [243]. 
The distribution of the fiber orientation can be ranged from -90o to 90o, where 0o 
indicates perfect alignment. The AD of nanofibers was measured from SEM 
micrographs using Image-Pro express software (Media Cybernetics, USA). The 
distribution and mean value of AD were obtained to quantify the degree of nanofiber 
alignment using circular statistics [244].  
 
 The surface topography was examined by atomic force microscopy (AFM) using a 
Nanoscope III AFM from Digital Instrument Inc. The arithmetic mean value of the 
surface roughness (Ra), which refers to the integral of the absolute value of the 
roughness profile height over the evaluated length approximated by a trapezoidal rule, 
was calculated and reported. 
 
 Water contact angle of the collagen nanofibrous scaffolds was measured to 
compare their hydrophilicity. Water contact angle was measured with the sessile drop 
method and a drop shape analysis system at 25°C using a Rame-Hart Model 100-230 
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goniometer. Each sample was measured at more than 3 different locations, and the 
averaged reading was reported. 
 
5.2.4 In vitro culture 
 
5.2.4.1 Cell adhesion assay 
 The crosslinked electrospun collagen scaffolds were placed at the bottom of a 24-
well plate. The scaffolds were fixed by hollow iron rings, sterilized by soaking in 75% 
ethanol for 30 min, and finally rinsed in sterilized PBS solution 3 more times. For the 
assessment of cell adhesion kinetics, rabbit conjunctiva fibroblasts (RCFs) harvested 
from Singapore National Eye Center as stated in Section 4.2.7.1 of Chapter 4 at a 
density of 5x104 cells/well were seeded onto the scaffolds. The cells were allowed to 
attach to the substrates for different intervals up to 9 h after seeding in a complete 
growth culture medium in a 5% CO2 incubator. The complete growth culture medium 
consisted of DMEM supplemented with 10% fetal bovine serum, 1 mM L-glutamine, 
and 100 U/ml penicillin. The density of attached cells on the scaffolds was assayed by 
the standard method of the MTT assay as shown below. 
 
5.2.4.2 Cell proliferation and morphology assay 
For cell proliferation study, RCFs were seeded on a 24-well culture plate fixed 
with the scaffolds described above but with a lower cell density (104 cells/well). The 
proliferation of RCFs on the scaffolds was quantified after days 1, 3 and 7 by MTT 
assay [206]. Briefly, the scaffolds attached with cells were incubated in a mixture of 
360 µl of medium and 40 µl MTT solution (5 mg/ml) in phosphate buffer saline (PBS) 
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for 4 h at 37°C and 5% CO2. The intense red colored formazan derivatives formed 
were dissolved with 400 µl dimethyl sulfoxide for 15 min and the absorbance was 
measured at 570 nm with a microplate reader (GENios, Tecan).  
 
The morphology of the adherent cells proliferating on the scaffolds was examined 
using SEM. To prepare the samples for SEM analysis, the samples were soaked in 
2.5% GTA PBS solution for 4 h for cell fixing and dehydrated in an ascending series 
of ethanol aqueous solutions (50%-100%) at room temperature. After freeze-drying, 
the samples were sputtered with platinum before SEM scanning. 
 
Immunohistochemistry staining was performed to observe and compare the 
differences of the morphology of the fibroblasts on the aligned noncrosslinked scaffold 
and the random nonwoven scaffold crosslinked by 0.02% GTA. Briefly, after 3 days of 
culture, the scaffolds were harvested, washed with PBS twice and fixed with 70% 
alcohol for 20 min in the incubator. After removing alcohol and washing with PBS 
twice, 20-30 µl popidium iodide (20 µg/ml) was added to stain the nucleus, and the 
stained cells were kept in the incubator for 30-40 min. After that, propidium iodide 
was removed and the cells were then washed with PBS twice and viewed under a laser 
scanning confocal microscope (LSCM, Leica TCS SP2, Germany). 
 
5.2.5 Statistical analysis 
 
The cell adhesion and proliferation experiments were performed in triplicate and 
the results were expressed as mean ± standard deviation (SD). Student’s t-test was 
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employed to assess statistical significant difference of the results as stated in Section 
4.2.7 of Chapter 4. Difference was considered statistically significantly at p<0.05.  
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5.3 Results and discussion 
5.3.1 Morphology of aligned nanofibrous scaffold  
 
The morphological structure of electrospun nanofibrous collagen was observed by 
SEM. As shown in Figure 5.2, though the alignment of every fiber was not perfect in 
the same orientation, a distinct regularity of the collagen fibers with a specific aligned 
longitudinal topography is shown on the aligned scaffold (ACL, Figure 5.2a). In 
comparison, the fibers on the random scaffold (RCL, Figure 5.2b) exhibited a more 
random orientation. ACL fibers with diameter ranging from 50 nm to 300 nm 
exhibited a smaller average diameter of 180 nm than RCL fibers with the average 
diameter of approximately 250 nm. The smaller ACL fiber diameter was due to the 
rotation of the wheel collector, which exerted a pulling force on the jet, and 
consequently reduced the size of the ACL fibers. Though using one rotating wheel 
could decrease the diameter of the electrospun nanofibers, the decrease of the diameter 
induced by the method is limited. Besides, at a much higher rotating rate, the wheel 
exhibited a force too strong that some breakages were observed on the fibers (not 
shown).Various approaches have been attempted to obtain aligned electrospun fibers 
[126]. These include spinning onto a rotating drum, spinning onto the sharp edge of a 
thin rotating wheel, introducing an auxiliary electrode or electrical field and, rapidly 
oscillating a grounded frame within the jet, and using a metal frame as the collector. 
Our experimental data suggest that a flexible wheel providing high rotational speed is 
the preferable design to achieve higher degree of fiber alignment. The aligned collagen 
fibers shown in this study exhibited a higher regularity than the collagen fibers 
collected by a rotating mandrel reported previously [185].  
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Figure 5.2 SEM micrographs of the collagen nanofibrous scaffolds, (a) ACL, (b) RCL, 
(c) X-ACL, (d) X-RCL. Arrow: the orientation of the aligned fibers. The mean 
diameter of ACL (180nm) is smaller than that of RCL (250nm) as observed on the 
inserts of Figures 5.2a and 5.2b. 
 
 
 During optimization of the electrospinning condition, it was found that a low 
rotational speed of 5 m/s cannot achieve acceptable fiber alignment. At a high 
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easily, especially for a biopolymer with lower strength and elasticity such as collagen. 
The optimal range of the rotational speed was found to be 10-20 m/s in our 
experimental conditions. However, the high degree of fiber alignment found in 
synthetic polymeric scaffolds as reported previously cannot be achieved in the collagen 
nanofibrous scaffold. In comparison with the synthetic scaffolds (AD = 6.5o) [243], the 
aligned collagen scaffold has a larger AD (10.7o) and wider orientation distribution 
(Figure 5.3). This is likely due to the fact that synthetic polymer are stronger and more 
elastic and has a higher electrospinniability. Besides, synthetic polymers are less likely 
to break when subjected to higher rotational speed, which is sometimes necessary to 
get aligned fibers. This was also proved by our previous electrospinning of aligned 
polycaprolactone (PCL) nanofibers in Figure 5.4b. Twice the rotating rate can be 
possible and higher alignment orientation could be achieved on the PCL nanofibers 
compared with the collagen ones in Figure 5.4a.  
 
It is well known that the pores or voids on RCL are formed by the overlaying of 
random oriented fibers during electrospinning (Figure 5.2b). By aligning the fibers, 
ACL exhibits a denser structure (Figure 5.2a) and a lower porosity than RCL. The 
pores observed on ACL are due to the imperfect alignment caused by the electrostatic 
repelling force between the deposited or depositing fibers, and subsequently alters the 
orientation of the fibers and leads to pores between the aligned fibers [190]. The 
different orientation of the aligned or random fibers also leads to different shape of 
pores between the fibers. As shown in the micrographs, smaller and narrower pores are 
commonly seen on ACL due to regularly depositing of ACL fibers, but bigger and 
rounder pores are shown on RCL.  
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Figure 5.4 Alignment of collagen and synthetic PCL nanofibers under the same 
process parameters using the rotating collector, (a) collagen, and (b) PCL. 
 













   97
 
Since native collagen exhibits undesirably high degradability, crosslinking of 
collagen is necessary to maintain the structural integrity of the scaffold before cells 
populate and new tissue regenerates [236]. For crosslinking in aqueous media, 
however, the collagen nanofibers may be eroded due to the degradation of collagen on 
the surface at initial crosslinking, and their desirable nano-scale dimension and 
porosity can be compromised. In this study, the crosslinking by GTA vapor was 
performed to keep the scaffold structure intact. As shown in Figures 5.2c and d, the 
dimension of the nanofibers and the overall porous morphology are preserved on both 
aligned and random collagen scaffolds after the GTA vapor crosslinking (X-ACL and 
X-RCL). The alignment of the fibers on X-ACL is also unchanged after exposed to 
GTA vapor and the subsequent washings.  
 
5.3.2 Surface Properties 
 
 The roughness (Ra) of the above four different collagen scaffolds determined by 
AFM is shown in Table 5.1. Higher Ra represents a rougher surface. The aligned 
collagen scaffolds (Ra of 70 nm for ACL and 55 nm for X-ACL) exhibited a lower 
degree of roughness than the corresponding random collagen scaffolds (Ra of 90 nm 
for RCL and 60 nm X-RCL). Therefore, regular alignment of the fibers may lead to 
smoother surface compared with the randomly oriented fibers. We also found that the 
crosslinked scaffolds have lower roughness than their noncrosslinked counterparts. 
This is most likely due to the crosslinking and the subsequent washing steps that may 
compress the scaffolds slightly and results in a more compact structure. As discussed 
later, roughness is also a significant factor influencing cell adhesion. 
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Table 5.1 Water contact angle and roughness of the collagen nanofibrous scaffolds. 
 














a RCL: the noncrosslinked random collagen scaffold; X-RCL: the crosslinked random 
collagen scaffold; ACL: the noncrosslinked aligned collagen scaffold; X-ACL: the 
crosslinked aligned collagen scaffold, Mean for n=5±SD. 
 
 
 Table 5.1 shows the water contact angle measurements of the different collagen 
nanofibrous scaffolds. The contact angles of ACL and RCL were 26o and 11o 
respectively. By crosslinking the scaffolds with GTA, the contact angles of both 
scaffolds increased substantially (41o for X-ACL and 30o for X-RCL). This was most 
likely due to the crosslinking reaction of GTA with collagen amine groups, which 
reduced the hydrophilicity of the surface of the fibers. In addition, aligned scaffolds 
(ACL and X-ACL) exhibited a higher water contact angle values than their random 
fiber counterparts. At first glance, it seems that the ACL (or X-ACL) was less 
hydrophilic than RCL (or X-RCL). However, since the chemical composition of both 
ACL and RCL (or X-ACL and X-RCL) was more or less the same as both scaffolds 
were made of pure type I collagen, both scaffolds should have the similar 
hydrophilicity. We believe that the observed difference in contact angles is most likely 
due to the difference in surface topography of these two scaffolds resulting from the 
different fabrication processes. As mentioned in the above SEM and AFM result, RCL 
was more porous and rougher than ACL. The rough surface yields a higher total 
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surface area at the water-scaffold interface. When a water droplet is placed on this 
surface, the larger contact area leads to a higher degree of interaction between the 
surface and the water droplet, resulting in higher extent of surface spreading of the 
droplet and consequently the observed lower contact angle (or higher wettability). 
Because of the use of the rotational wheel during fabrication, ACL has a smoother 
surface, and thus the water droplet spreading in this surface is less and the observed 
contact angle is larger. 
 
5.3.3 Cell adhesion and proliferation 
 
 The adhesion of rabbit conjunctiva fibroblasts (RCFs) at 1-9 h after seeding onto 
different scaffolds was determined by the MTT assay. As shown in Figure 5.5, the 
percentage of the seeded cells adhering on both X-ACL and X-RCL increased rapidly 
initially and it approached a plateau after 7 h of seeding. X-ACL exhibited a lower 
degree of cell adhesion at any time point compared with X-RCL (p<0.05). This 
observation can be attributed to the surface roughness difference between X-ACL and 
X-RCL. The roughness of the surface has been reported to play an important role in 
cell adhesion [245]. From the Ra value mentioned earlier, X-ACL has a smoother 
surface because of the regular fiber alignment compared with X-RCL. The smoother 
surface most likely reduced the possible surface interaction when RCFs first contact 
the surface, resulting in the low degree of adhesion observed in X-ACL. In addition, 
since cell spreading mostly happens along the aligned orientation of the fibers [114, 
190], the regular orientation of the fibers on X-ACL may inhibit the initial cell 
spreading at all direction. Consequently the cells may have a less stable anchorage on 
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X-ACL and be removed from the surface easily by shear force during surface washing, 












Figure 5.5 RCF adhesion on the crosslinked aligned (X-ACL) and random (X-RCL) 
collagen nanofibrous scaffolds analyzed by MTT assay, mean for n=3±SD. p<0.05 
comparing between X-ACL and X-RCL at every time point. 
 
 RCF proliferation on X-ACL and X-RCL at day 1, 3 and 7 was analyzed by MTT 
assay and is shown in Figure 5.6. The representative SEM micrographs of RCFs 
cultured at day 3 and 7 are also shown in Figure 5.7. Both results show that the cell 
density increases continuously on the both scaffolds during the culture period, 
suggesting that the nanofibrous collagen scaffold can be used as a native ECM analog 
to provide a suitable environment for cell proliferation. In addition, on each time point, 
a higher cell density is found on X-ACL than X-RCL (p<0.05). The SEM micrographs 
at day 7 also show that RCFs reached a higher degree of confluence on the X-ACL 
(Figure 5.7c) than on X-RCL (Figure 5.7d). The regular alignment of the scaffold may 
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proliferation is that the mechanical stretching of the aligned nanofibers in cultured 
fibroblasts may lead to better cell proliferation. This phenomenon is similar to the 























Figure 5.6 RCF proliferation on the crosslinked aligned (X-ACL) and random (X-RCL) 
collagen nanofibrous scaffolds analyzed by MTT assay, Mean for n=6±SD. (*) p<0.05 
compared with X-RCL at each time point. 
 
 
 It is well known that the aligned fibers collected from a rotational wheel are 
stretched and under physical stress by the rotational motion of the wheel collector. In 
addition, the regular alignment on X-ACL guided the spreading direction of the 
adherent cells, which allowed the cells occupying the space more compactly, and 
consequently more cells could be packed within the fixed size of the scaffold surface 
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RCL, especially at longer proliferation period when the population of the cells was 
high.  
 
5.3.4 Cell morphology and cell-scaffold interaction 
 
The SEM micrographs in Figure 5.7 show the morphology of RCFs on X-ACL 
and X-RCL. As mentioned above, most cells adhered and elongated themselves along 
the alignment direction of the nanofibers on X-ACL, whereas the cells on X-RCL 
appeared to be spreading at all direction (Figures 5.7b and d). Fibroblasts on the 
random nanofibrous scaffold remained randomly oriented and the cellular nuclei were 
more circular compared with that on the aligned scaffold (Figure 5.7e and f). Although 
some cells did not follow the trend, it is obvious that most cells elongated along the 
alignment direction on X-ACL, and they have a spindle-like appearance parallel to the 
direction. Comparing the micrographs at days 3 and 7 (Figures 5.7a and c), the cells 
elongated more uniformly along the fiber direction at a longer incubation period, 
suggesting that the fibers may regulate the cell orientation during proliferation. This is 
an important finding because the elongated proliferation pattern of the cells coincided 
with the morphology of fibroblasts found in many native tissues [114, 246]. It is 
known that cell growth, spreading, and orientation can be controlled by the materials 
surface chemistry or topography. Therefore, the electrospinning of a well-defined 
architecture of the scaffold can be very useful for engineering different specific tissues 
or organs when the mimicking organization or arrangement is needed. A better 
understanding and control of cell-matrix interactions is nowadays thought to be 
achievable by a more precise control of the cell growth and orientation at the nano-
scale. 
Chapter 5 
   103
 
Therefore, controlling cellular environment using electrospinning fabricated 
nanopatterning may be used for directing cell fate for tissue engineering applications. 
It is envisioned that the incorporation of such patterning approaches can be used to 



























































Figure 5.7 Micrographs of RCFs on the crosslinked collagen scaffolds after 3 and 7 
days culture, (a) X-ACL, 3 days; (b) X-RCL, 3 days; (c) X-ACL, 7 days; (d) X-RCL, 7 
days, (e) X-ACL, 3 days, (f) X-RCL 3 day, a-d, SEM micrographs, e-f: LSCM 
micrographs, Arrow: the orientation of the aligned fibers. 
f e 
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5.4 Conclusions 
 
 In this chapter, the aligned collagen scaffold by electrospinning with a rotational 
wheel collector was fabricated. This scaffold exhibits a distinct fiber alignment 
compared with the random fibrous one fabricated without the use of the rotational 
wheel collector. Cell adhesion and proliferation of RCF were evaluated by MTT assay. 
Decreased cell adhesion but increased proliferation were found on aligned collagen 
scaffold compared with random collagen one. Cell proliferation with spindle-like 
appearance along the orientation of the fibers was demonstrated by SEM. The 
elongated proliferation pattern of the cells coincides with the cell morphology found in 
many native tissues, indicating that the aligned collagen nanofibrous scaffold can be 
very useful for engineering different specific tissues or organs. 
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Chapter 6 
 
Electrospinning of collagen and blended collagen-GAG 
nanofibers using acetic acid as solvent 
 
6.1 Introduction  
 
 A wide range of electrospun fibers made of synthetic polymer and biopolymer can 
be applied commercially for the production of filtration system, medical prosthesis, 
tissue template, and electromagnetic shielding [125, 247-250]. The parameters 
influencing electrospinning can broadly be classified into polymer solution properties 
and processing conditions, and have been covered in detail in the literatures [228, 230, 
231, 251]. Despite considerable recent progress on the electrospinning process and a 
rapid increase in the number of the publications on electrospinning, serious challenges 
still remain. As electrospinning involves thermal and mass transport or solvent 
evaporation, the mechanisms of jet formation and motion in the electrospinning 
process have not been fully understood yet [252], and an effective model for accurately 
predicting or controlling the electrospinning jet is unsolved [253]. Besides, the 
characteristics of solvents suitable for electrospinning are not well investigated, 
although it is widely accepted that solvents with high dielectric value or good 
conductivity are excellent for electrospinning. Optimal solvent conditions must be 
determined for electrospinning each new polymer or polymer blend system. 
Furthermore, the difficulties in electrospinning of many biomacromolecules still 
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remain, and nanofibers smaller than about 50 nm in diameter cannot currently be 
produced uniformly and repeatedly. 
 
 Electrospun nanofibers are being investigated for various biomedical areas 
including tissue engineering, medical prostheses, wound dressing, and drug delivery 
[254, 255]. Applications in the tissue engineering field are most promising because all 
human tissues such as blood vessel, cartilage, bone, nerve and skin are composed of 
nanofibrous structures from a biological viewpoint, and this nanofibrous architecture 
may be replicated using electrospinning [110, 114, 256]. Viable solutions for 
controlled electrospinning techniques may lead to the feasibility of fabricating a well-
defined architecture for guiding cell growth and development in a fashion similar to 
the specific patterning of native extracellular matrix (ECM) in many tissues where 
specific mimicked structure are needed [114]. 
 
 Though several effective solvents such as 1,1,3,3,3 hexafluoro-2-propanol (HFP), 
trifluoroethanol (TFE) and hydrochloric acid (HCl) are currently available for 
electrospun collagen blended with other components [233, 237, 257], only HFP has 
been identified to be a suitable solvent for electrospinning of pure collagen nanofibers 
[185, 187]. However, the high toxicity of HFP may pose a health problem to users 
such as acute nausea and dizziness and kidney damage under subchronic inhalation 
exposure conditions. In vivo implantation of HFP treated collagen was reported to 
recruit inflammatory cells within and around the implant [258]. Therefore, a less toxic 
solvent is preferable to minimize any toxicity problem in biomedical applications or 
health problem in the product fabrication. Besides, the high cost of HFP may also be 
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negative factor for wider application of the nanofibers as the high cost of solvent may 
increase the price of related medical products. 
 
 Acetic acid (HAc) has been one safe solvent for preparing collagen gel/sponge for 
biomedical application. But only weak acid solution was widely used in past 
applications, and this collagen solution failed to form nanofibers during 
electrospinning. Highly concentrated HAc already has been reported to be a suitable 
solvent for electrospinning chitosan. In this chapter, we reported the use of HAc as a 
safer and cheaper solvent for electrospinning pure collagen. Electrospinning pure 
collagen using HAc, which has not been reported, may have the potential to overcome 
the current difficulty in fabricating collagen nanofibers. HAc may also be a potential 
solvent for electrospinning other biopolymers, such as elastin and fibrinogen that have 
been electrospun only in HFP [237, 259]. As discussed in Chapter 4, 
glycosaminoglycans (GAGs), as a group of polysaccharides, are a common constituent 
of cell surfaces and the ECM as binding and modulating enzymes, protease inhibitors 
and cytokines [196, 212, 238]. GAGs are also important factors influencing 
contraction and arrangement of the collagen fibrils [175, 215]. Incorporation of GAG 
into collagen nanofibers may modulate biocharacteristics and physical properties of 
collagen nanofibers. In the present study, electrospinning of blended collagen with 
chondroitin sulfate, a common GAG, was also investigated using the optimal HAc 
solution and compared to the study of Chapter 4 which used TFE/water.  
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6.2 Experimental section  
 
6.2.1 Materials  
 
 All chemicals and reagents were purchased from Sigma-Aldrich unless specified 
separately. Main chemicals and reagents used in this study included calf skin type I 
collagen, glacial acetic acid (Fluka), 1,1,1,3,3,3 hexafluoro-2-propanol (HFP), 
chondroitin-6-sulfate (CS) sodium salt from bovine trachea, GTA, glycine (Alfa 
Aesar), Dulbecco’s modified eagle’s medium (DMEM, Gibco), and fetal bovine serum 
(FBS, Hyclone). 
 
6.2.2 Properties of collagen solutions for electrospinning 
 
 Collagen solutions at different concentrations were prepared by dissolving calf skin 
type I collagen in HAc solutions at various ratios of glacial HAc to water. The 
viscosity measurements of the collagen solutions were conducted with an Ostwald U-
tube viscometer (Technico), and the viscosity of collagen solutions at different 
collagen concentrations from 0.5 wt%-20 wt% were measured. Surface tension of the 
collagen solutions was determined by a drop shape method (FTA125, First Ten 
Angstroms). The electrical conductivity of the collagen solutions was determined using 
a conductivity flow cell (Biorad). The different collagen solutions at HAc 
concentration of 15%-100% was tested for surface tension and viscosity measurements.  
 
6.2.3 Electrospinning and characterization of collagen nanofibers  
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 An electrospinning set-up as documented previously [43] was used to fabricate 
collagen nanofibers. The collagen solutions used in the experiments contained 5-13 
wt% of collagen and 50-100 % (v/v) HAc. A syringe pump was used to feed the 
collagen solution into the needle tip at a feed rate of 1.0 ml/h. A voltage of 15 kV was 
applied across the solution and the collector, with the distance between the needle and 
the collector set at 18 cm. These processing conditions were found to be most suitable 
for electrospinning of collagen solution in HAc. The collagen nanofibers were 
collected on 15 mm diameter glass coverslips and dried under vacuum overnight to 
remove the residual solvent. A blended collagen solution (13 wt%) with 1.3 wt% 
chondroitin sulfate (i.e. 10% w/w of collagen) was also electrospun under the above 
spinning condition.  
 
 Surface morphology of the electrospun fibers was observed by scanning electron 
microscopy (SEM). Platinum was sputtered onto the surface of the samples before 
SEM observation. The SEM scanning was performed at an accelerating voltage of 15 
kV. To prepare samples for thermogravimetric analysis (TGA) measuring the 
incorporated solvent content in the scaffold, collagen nanofibers were collected on the 
teflon substrate as collagen nanofibrous layer was easily peeled off the Teflon 
substrate. The samples were then vacuum dried overnight before TGA. TGA was 
performed at 30-480ºC at a 10ºC/min ramp under N2 atmosphere.  
 
6.2.4 Cell culture  
 
 Human conjunctival fibroblasts (HCFs) were harvested and cultured from human 
conjunctiva at the Singapore Eye Research Institute as stated in Section 3.2.6.1 of 
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Chapter 3. The in vitro toxicity of the electrospun collagen nanofibers caused by the 
residual solvents HAc and HFP was evaluated by MTT assay in comparison. The 
samples were fixed at the bottom of a 24-well plate by iron rings. HCFs were seeded 
on a 24-well culture plate at a density of 1.0x104 cells/well using the previous 
fibroblast culture media. In vitro cell proliferation on the scaffolds was assayed by 
MTT assay after 2 and 5 days of incubation as stated in Section 3.2.6.2 of Chapter 3.  
 
 The morphology of the adherent cells on the HAc electrospun collagen also was 
observed using SEM. Before in vitro cell culture, the HAc electrospun collagen 
samples were exposed to 10% GTA vapor for 10 hours for crosslinking and then 
soaked 30 min in 75% ethanol and rinsed through sterile phosphate buffered saline 
(PBS). To prepare the samples for SEM analysis, the scaffolds with cells were washed 
twice by PBS followed by GTA fixation for 4 h and dehydration in a series of 
ethanol/water solutions (50%-100%). Finally, the samples were dried and platinum 
was sputtered onto the surface of the samples before scanning. 
 
6.2.5 Statistical analysis  
 
 The cell proliferation were performed in triplicate and expressed as mean ± 
standard deviation (SD). Student’s t-test was employed to assess statistical significant 
difference of the results as described in Section 3.2.7 of Chapter 3. Difference was 
considered statistically significant at p<0.05. 
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6.3 Results and discussion 
6.3.1 Electrospinnability of collagen in HAc  
 
6.3.1.1 HAc concentration effect  
 
 Generally the solvent selected to prepare the polymer solution has a predominant 
influence on the electrospinnability of the resultant polymer solution. Dilute aqueous 
acetic acid (HAc) solution is a widely used solvent to prepare collagen solutions in 
many biomedical applications. HAc below 3% (v/v) is commonly used to form porous 
collagen gel or sponge for biomedical applications [57, 260]. In our experiments, 
however, 50% or less HAc solution yielded no collagen nanofibers. In order to 
evaluate the electrospinnability of collagen in HAc solution, we measured three 
solution properties: viscosity, surface tension, and conductivity of a 13 wt% collagen 
solution with various HAc concentrations from 15 to 100% (v/v). Our experiments 
showed that the viscosity of the collagen solution mainly depended on collagen 
concentration and did not change significantly at various HAc concentrations (data not 
shown). However, HAc concentration significantly influenced the surface tension as 
summarized in Figure 6.1. The surface tension of the collagen solution decreased 
significantly from 57 to 29 dyne/cm with increasing HAc concentration from 15% to 
100% (v/v). This is because acids generally exhibit lower surface tension and can be 
used as a surfactant to decrease the surface tension of a blended mixture. Nanofibers 
formation could be observed with 50% (v/v) HAc concentration (Figure 6.2a), but 






















Figure 6.1 Surface tension and conductivity of the 13 wt% collagen solution at the 






























Figure 6.2 SEM micrographs of the electrospun 13% collagen solution in the different 
HAc concentrations, (a) 50%, (b) 80%, (c) 90%, (d) 100%. 
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 Our experiment work showed that a collagen solution at lower 50% (v/v) HAc was 
found to be difficult to electrospin into continuous fibers, and only particles were 
observed even if a high voltage was used. This suggests that the electrostatic forces at 
the surface of the collagen solution cannot overcome the resultant high surface tension, 
and thus no nanofiber was formed. At 80-100% (v/v) HAc, nanofibrous morphology 
was formed due to the decreased solution surface tension. Different fiber morphologies 
were observed at various concentrations of HAc as seen in Figures 6.2b-d. Nanofibers 
with some beads were found on the electrospun morphology of collagen solution in 
80% (v/v) HAc (Figure 6.2b) and uniform nanofibers with few beads were observed at 
90% (v/v) HAc concentration (Figure 6.2c). At 100% (v/v) HAc, some bead formation 
was observed (Figure 6.2d). This re-occurrence of beads may be explained by the 
change in solution conductivity as below. 
 
 The conductivity of the solution is an important factor influencing the 
electrospinnability of the polymer. The electrospinning solution can be stretched into 
continuous fibers only when the solution has sufficient repulsion due to the charge at 
its surface. Generally this dielectric characteristic of the solution is evaluated by 
measuring the conductivity of the solution. Figure 6.1 shows that collagen in pure HAc 
exhibited an extremely low conductivity as glacial HAc has extremely low 
conductivity of 0.01-0.05 mS/m. The addition of 10% (v/v) water remarkably 
enhanced the conductivity of the collagen solution from almost zero to 36.2 mS/m due 
to the ionization of HAc. This acid ionization may lead to significantly increased ionic 
strength and thus the conductivity of the solution could be increased remarkably. 
Besides, the higher ionic strength may also enhance the dielectric constant of the 
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solution. This also may be partially attributed to increased dielectric characteristics of 
the collagen solution. Therefore, though both water (0.23 ± 0.05 mS/m) and HAc are 
poorly conductive solvents, the mixture of the two creates a conductive solvent leading 
to the improved conductivity of the resultant collagen solutions. For 13 wt% collagen 
in pure HAc, the low conductivity of the solution cannot provide enough repulsion of 
the charges at the solution surface. Thus the solution may not be fully stretched during 
electrospinning, leading to the re-occurrence of bead formation as observed in Figure 
6.2d. Therefore, the water component is important for electrospinning solution system 
due to the increased conductivity (or dielectric constant). However approximately 10% 
water in HAc was found to be most suitable for collagen electrospinning with little 
bead formation (Figure 6.2c). Higher water content (for example, 20%) caused a 
decrease in the solvent evaporation and slowed the solidification of electrospun 
nanofibers, and the resultant fibers appeared to be flatter and more irregular (Figure 
6.2b). The observed bead formation was likely due to instability of solvent system 
induced by the increased charge density. In addition, the extra electric charge density 
may cause fibers to split into a smaller ones which was already discussed in the 
literatures [252, 261] and spider web structure was also observed  as documented 
previously [235]. It was also found that the collagen solution in low HAc concentration 
(15%) exhibited a declining conductivity (Figure 6.1) due to significantly decreased 
ionization of HAc, but the high content of water was not suitable for electrospinning 
collagen due to the high surface tension as discussed previously and low volatility of 
water which is not suitable for nanofiber solidification.  
 
 In a separate experiment, 50 mM NaCl was added to pure HAc for electrospinning. 
This is a common method to enhance the conductivity of polymer solutions. But the 
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addition of NaCl into pure HAc did not increase the conductivity of the collagen 
solution much, and no improvement in the morphology of the resultant electrospun 
fibers was observed (not shown). This is likely due to the extremely low solubility of 
inorganic salt in glacial HAc. Therefore, the addition of water was found to be more 

























6.3.1.2 Collagen concentration effect  
 Electrospinning of non-beaded fibers requires appropriate solution viscosity, which 
is generally correlated with the weight concentration of polymer solution. In order to 
find the appropriate collagen concentration for electrospinning, the solution viscosity 
at various collagen concentrations (90% (v/v) HAc) was measured and the 
corresponding electrospun fiber morphology was scanned. As shown in Figure 6.4a, at 
5% collagen concentration (viscosity of 350 cP, Figure 6.3) microparticles instead of 
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the usual continuous fibers were obtained. This suggested that the chain entanglement 
within the low collagen concentration solution is not enough to spray into a continuous 
jet. Only droplets were sprayed and solidified into microparticles. At 8 wt% 
concentration, continuous nanofibers with excessive beads were found (Figure 6.4b). 
Further increase to 10 wt% concentration yielded fibers with fewer beads (Figure 6.4c) 
compared with Figure 6.4b. At 13 wt% concentration, almost no bead formation was 
observed (Figure 6.4d). The corresponding fiber diameter ranged from 100 to 600 nm 
which is the typical size for collagen fibers spun in HFP as shown in chapter 3 or 
chapter 4. At 18 wt% concentrations, the collagen solution was highly viscous with 
some collagen precipitation. The tip of the needle was easily jammed by the viscous 
solution and such solution could not be ejected out even after applying a higher voltage. 
Therefore, the 13 wt% collagen solution in 90% (v/v) HAc was determined to be the 
appropriate solution system for the effective fabrication of nanofibrous collagen. The 
resultant fibers exhibited uniform nanofibers with an average diameter of 370 ± 50 nm 
(Figure 6.4b). The scaffolds exhibited significantly fewer beads than those of the other 
collagen solutions.  
 
 As shown in Table 6.1, the solution properties of this collagen solution, such as 
conductivity, surface tension, and viscosity, were similar to that of collagen solution in 
HFP, the solvent reported previously for electrospinning pure collagen nanofibers 
[185]. This study verifies the electrospinnability of collagen using HAc as the solvent, 
and can replace HFP for alternative electrospinning solvent since HFP is highly toxic 
and very expensive. However, HFP still has shown high flexibility and effectiveness 
for electrospinning collagen. 
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Table 6.1 Solution properties of collagen dissolved in HFP and HAc. 
 





Collagen in HFP 25 ± 2.5 38.3 ± 4.1 650 ± 50 
Collagen in HAc 31 ± 3 36.2 ± 2.5  820 ± 70  
 
a Collagen in HFP: 8 wt% collagen dissolved in HFP; Collagen in HAc: 13 wt% collagen 
dissolved in 90% HAc; blended collagen in HAc:  b The conductivity of pure HFP, HAc and 


































Figure 6.4 SEM micrographs of the electrospun collagen solutions in the 90 v/v% HAc 
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6.3.2 Electrospinnability of blended collagen-GAG in HAc 
 
 Incorporation of GAG into other bulk biocomponents or polymers may have 
application in soft tissue engineering as GAG is an important component in native 
tissue. Electrospinning of pure GAG is not feasible because of its low solubility in 
most organic solvents, but the formation of blended collagen-GAG nanofibers has 
been reported previously in Chapter 4 using a mixture of trifluoroethanol (TFE) and 
water as the solvent. However, only a particular ratio of GAG to collagen could be 
used in the given mixed TFE-water solvent. Once the ratio of TFE and water changed, 
a different collagen-GAG ratio was required. This made electrospinning collagen-
GAG nanofibers more difficult. In addition, only a 4% or lower GAG concentration 
could be spun in a mixture of TFE and water to form uniform nanofibers.  
 
 In this chapter, an aqueous HAc solution was used to dissolve blended collagen 
and GAG to investigate its electrospinnability. The water component in aqueous HAc 
solution allowed easy solubilization of GAG, and excellent miscibility between water 
and HAc provided a better solvent system for electrospinning blended collagen and 
GAG. Our work proved that at least 10% GAG and collagen could be dissolved in 
90% HAc to form a homogeneous solution. The electrospun nanofibers exhibited 
uniform morphology with few beads as observed in Figure 6.5a. When the GAG 
concentration was increased to 15%, the resultant solution appeared to be remarkably 
milky due to some GAG precipitation. Though continuous nanofibers could still be 
obtained, some bead formation was found (Figure 6.5b). Having said this, a wider 
range of GAG concentrations could be used with the aqueous HAc solution, compared 
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to mixed TFE and water indicating that HAc solution is a better solvent in 

















Figure 6.5 SEM micrographs of the blended collagen-GAG (13%) at the different 
GAG concentrations, (a) 10 wt% GAG, (b) 15 wt% GAG. 
 
6.3.3 In vitro test  
6.3.3.1. The effect of solvents on the biocompatibility of the electrospun collagen 
 
 Thermogravimetric analysis (TGA) is a thermal analysis technique used to measure 
changes in the weight of a sample as a function of temperature. TGA is commonly 
used to determine polymer degradation temperatures, absorbed moisture content, 
residual solvent levels, and the amount of inorganic (noncombustible) filler in polymer 
or composite materials. Here, TGA was used to measure the content of solvents in the 
nanofibers. Figure 6.6 shows TGA curves of the received collagen powder and the 
collagen nanofibers electrospun using HFP and HAc. The TGA curves presented the 
weight loss during heating from 30 to 480oC. The two electrospun collagen showed a 
fast weight reduction at 150–250oC, while the received collagen only exhibited a 
(a) (b)
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gradual weight reduction. This was due to the evaporation of HFP and HAc 
incorporated in collagen nanofibers during electrospinning process. The content of 
HFP and HAc remained in the fibers was about approximately 9.85 wt% and 13.31 
wt% respectively with reference to the weight loss curve of the received collagen. 
Higher HAc content in the collagen nanofibers compared with the HFP spun collagen 
was likely due to the lower evaporation rate of HAc than that of HFP. This result 
showed the presence of solvent in the electrospun fiber as in the previous study [210]. 
The residual solvent may cause potential biosafety problem when the nanofibers are 
applied in biomedical field. Inflammatory response may occur when the solvents are 
























Figure 6.6 Thermogravimetric analysis (TGA) curves of the received collagen and the 
collagen nanofibers electrospun by using HFP and HAc. 
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 Figure 6.7 shows that cell proliferation of human conjunctiva fibroblasts (HCFs) 
on the electrospun collagen scaffolds using HFP and HAc solvents. Tissue culture 
plate (TCP) was used for a control. The electrospun collagen scaffolds without 
crosslinking were used here because the crosslinked collagen exhibited significant low 
degradation rate and the release of solvents was delayed. The electrospun collagen by 
HFP and HAc exhibited a significantly increased cell proliferation than TCP from days 
2 to 5. This suggested that the excellent biological activity of the collagen scaffolds 
coupled with the high surface area and high porosity formed by electrospinning 
















Figure 6.7 Cell proliferation on the surface of the HFP and HAc electrospun collagen 
with a control of TCP surface, TCP: the tissue culture plate, HFP: the HFP electrospun 
collagen, HAc: the HAc electrospun collagen, (*) p<0.05 compared with TCP, (#) 
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 Cell proliferation increased slightly on the HAc nanofibers compared to on the 
HFP ones, especially on days 5 when the collagen nanofibers was mostly degraded and 
the solvent fully released into the culture media, confirming that the HAc nanofibers 
exhibited lower cytotoxicity than the HFP nanofibers. HFP is a highly toxic solvent 
that can inhibit cell growth, whereas HAc may only cause slight reduction of 
extracellular or intracellular pH [262, 263]. However, the pH reduction was not 
remarkable during in vitro incubation and the acidification may be noncytotoxic. The 
buffering capacity of the culture media is most likely sufficiently large to compensate 
any major fluctuation of pH caused by HAc released from the fibers. However, HFP 
also cause a potential safety problem for lab use as it is highly toxic and irritative to lab 
users. 
 
6.3.3.2. Cell morphology on collagen nanofibers 
 
 The suitability of the HAc electrospun collagen nanofibers was examined by 
culturing HCFs for up to 4 days on the nanofibrous scaffolds. Figure 6.8 shows that 
HCFs proliferated well and exhibited typical fibroblast morphology on both 
crosslinked and noncrosslinked collagen based scaffolds. This indicates that the 
scaffolds exhibited good biological properties and physical support for cell growth. 
The noncrosslinked collagen nanofibers (Figure 6.8a) degraded to some degree, 
leading to sparse structure of nanofibers. The crosslinked scaffold, however, was still 
relatively intact after 4 days (Figure 6.8b). This suggested that crosslinking led to 
increased biostability and structural integrity of collagen nanofibers, and might provide 
more versatile physical support for cell growth. 
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Figure 6.8 SEM micrographs of HCFs growing on the HAc electrospun collagen 
nanofibers after 4 days, (a) the noncrosslinked collagen, (b) the crosslinked collagen. 
The crosslinked collagen scaffold (b) exhibited an intact structure, while the 
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6.4 Conclusions  
 
 Though electrospinning of collagen has been developed recently and the 
application of electrospun collagen is attracting much interest in biomedical 
applications, the well-known difficulty in the electrospinning of collagen nanofibers 
still remains. This study described the novel use of HAc as an electrospinning solvent 
to fabricate collagen nanofibers. The solution parameters were discussed fully and the 
optimal solution condition for electrospinning was determined. Our study shows that 
low HAc concentration (high water content) exhibited high surface tension and failed 
to electrospin collagen nanofibers. The presence of water, however, plays a significant 
role on increasing the electrospinnability of collagen solution by improving the 
conductivity of solution due to the increased ionization of HAc. A small 10% water 
content in the HAc solution was found to be optimal for collagen electrospinning. HAc 
solution was also more advantageous in electrospinning blended collage-GAG due to 
the higher solubility of GAG and a better miscibility of the solvent mixture. The 
potential of applying collagen based nanofibrous scaffolds is promising as collagen 
nanofibers exhibited excellent biological and physical properties for cell growth in our 
in vitro study.  
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Chapter 7 
 
Enhanced biological stability of collagen with 




As discussed in previous chapters, collagen nanofibers exhibit high surface area to 
volume and nanofibrous topography is favorable for cell growth. However, the current 
electrospun collagen nanofibers only was found to only support 2-dimensional cell 
growth and migration. The cells cannot migrate into the fibrous scaffold because the 
pores (roughly 1-5 µm) is too small compared with the size of cells (50-100 µm). To 
make the porosity useful for cell migration is also new research direction for 
electrospun nanofibers. Meanwhile, collagen gel may still exhibit potential in suitable 
corneal construction for transplantation if the mechanical strength and biostability of 
collagen could be increased significantly. To achieve this aim, herein we report two 
widely used crosslinking methods that were modified using highly functional 
dendrimers to improve the performance of collagen.  
 
 As a new class of polymeric materials, dendrimers have attracted much interest 
since their introduction in the mid-1980s due to the unique architecture with a central 
core, surface functionalities and branching units linking the two [264, 265]. Unlike the 
traditional linear polymer, a dendrimer possesses special physical and structural 
characteristics of: the compact and well-defined structure, the large number of end 
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groups, which can be reactive, and the possibility to encapsulate guest molecules 
between the branches. This specific structure of the dendritic interior and functional 
end groups make a dendrimer suitable for a broad scale of applications. Dendrimer use 
has been reported for catalysts or catalyst supports, drug delivery and polymer 
additives [265, 266]. In catalyst chemistry, dendrimer are used to enhance the 
selectivity and reaction rate by constructing dendrimers with the selective catalytic 
groups and magnifying contact surface of smaller catalyst molecules [267, 268]. There 
are also attempts to use dendrimers in the targeted delivery of drugs and other 
therapeutic agents for gene or anti-sense therapy. Drug molecules can be efficiently 
loaded both in the interior shell of dendrimer as well as conjugated with the surface 
groups. Due to a large number of terminal groups and high branch structure, especially 
for high generation of dendrimer, one dendrimer molecule is capable of carrying drugs 
at a high density. Recently, the large-scale availability of dendrimers may extend their 
potential applications [270].  
 
 In biological application, although collagen is a broadly used biomaterial, it often 
exhibits weak strength and unacceptably high biodegradability not suitable for the 
specific demands of the tissue scaffolding. It is widely accepted that the mechanical 
strength and biostability of collagen can be enhanced by many crosslinking agents [57, 
195, 198, 236, 271]. The two commonly used crosslinking methods for collagen are 
aldehyde (such as glutaraldehyde (GTA) and formaldehyde) and carbodiimide (such as 
N-(3-dimethylaminopropyl)-N-ethylcarbodiimide hydrochloride (EDC) and cyanamide) 
[57, 272]. Notably aldehyde crosslinking can provide a high degree of crosslinking by 
bridging amine groups between two adjacent polypeptide, but it evokes cytotoxic 
reactions due to the release of unreacted aldehyde and aldehydic derivatives during in 
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vitro and in vivo degradation [272-274]. As another commonly used crosslinker, 
carbodiimide (enhanced by hydroxysuccinimide (NHS)) is employed as zero-length 
crosslinker to form amide bonds between carboxylic acid groups and amino groups 
without alkyl spacers between molecules [275]. Carbodiimide crosslinking of collagen 
is preferred for biomedical application due to its lower cytotoxicity compared with 
GTA. However, the biostability and structural integrity of crosslinked collagen by 
carbodiimide is much lower than the one by GTA [222, 276].  
 
 Dendrimer itself can be used as a potential crosslinking agent as the reactive 
surface groups of a dendrimer can be conjugated with other molecules or functional 
groups. In this chapter, primary amine terminated polyamidoamine (PAMAM) 
dendrimer, which is based on an ethylenediamine core and branched units, was 
incorporated in the GTA and EDC/NHS crosslinking of collagen. A dendrimer with 
multiple amine groups was hypothesized to promote the crosslinking density due to the 
increased bonds/bridges between collagen molecules and/or crosslinkers. The 
biostability and biological properties in vitro of the crosslinked collagen were 
evaluated to investigate the effect of dendrimer incorporation in the two crosslinking 
methods.  
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 All the chemicals and reagents were purchased from Sigma-Aldrich unless 
specified separately. Main chemicals and reagents used in this study include: Calf skin 
type I collagen (Fluka), GTA, glycine (Alfa Aesa), N-(3-dimethylaminopropyl)-N-
ethylcarbodiimide hydrochloride (EDC), sodium hydrogen phosphate (Na2HPO4, 
Fisher biotech), 3-(4,5-dimethylazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide 
(MTT), type I collagenase from Clostridium histolyticum, micro bicinchonic acid 
(BCA) protein assay kit (Pierce), Dulbecco’s modified eagle’s medium (DMEM, 
Gibco), fetal calf serum (FBS, Hyclone). N-hydroxysuccinimide (NHS, Fluka), 2-(N-
Morpholinoethanesulfonic acid) buffer (MES). Amine terminated polyamidoamine 
(PAMAM) dendrimer (generation 2) was received as a 20 wt% solution in methanol. 
Before use, the aqueous dendrimer stock solution was prepared by diluting the 20 wt% 
methanol solution with deionized water to the needed concentrations of dendrimer 
followed by the evaporation of methanol. 
 
7.2.2 Crosslinking of collagen scaffolds  
 
 1 wt% collagen acidic solution was prepared by dissolving collagen in 0.3% (v/v) 
acetic acid solution. The pH of the collagen solution was modified by 1 N NaOH to 5.5. 
0.1 mmol PAMAM in the above stock solution was added into the collagen solution 
and after 1 h incubation, 1 ml of 50 mM MES (pH=5.5) solution containing 100 mM 
EDC and 50 mM NHS was mixed with 1 ml above collagen solution. Thus the 
Chapter 7 
   130
crosslinking solution contained 0.5 wt% collagen, 50 µΜ PAMAM, 50 mM EDC, and 
25 mM NHS. GTA crosslinking with PAMAM was performed in the same way with a 
final concentration of 0.02 wt% GTA, 0.5 wt% collagen, and 50 µΜ PAMAM. The 
EDC/NHS and GTA crosslinked collagen without PAMAM were also prepared under 
the identical conditions for comparison. All the resultant collagen scaffolds were 
placed at 4oC overnight for gel formation and the residual agents were removed by 
soaking the gel in water for 3 h six times. Finally collagen scaffolds were freeze-dried 
and stored for further characterization and biological test. 
 
7.2.3 Collagenase digestion 
 
 The collagen scaffolds for collagenase assay were cut into filmy membrane pieces 
with similar shape and weight. The amount of collagen digested in collagenase 
solution was measured by the BCA total protein assay. Accurately weighed collagen 
samples were incubated for 1 day in collagenase solution in PBS (activity of 394 unit 
per mg) at 37oC. Then 25 µl of supernatant was transferred to a 96-well plate 
containing 200 µl/well BCA reagent. The plate was incubated at 37oC for 30 min, and 
then cooled to room temperature for 20 min. The absorbance was measured 
immediately using a GENios microplate reader at 540 nm wavelength (GENios, 
Tecan). The amount of collagen was determined by comparison with the standards of 
known protein concentration. The mass loss of the collagen scaffold was expressed as 
the percentage of the original collagen scaffold mass. 
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7.2.4 Differential Scanning Calorimetry  
 
 Differential scanning calorimetry (DSC) was performed with a DSC-822 
instrument (Mettler-Toledo). 5-10 mg of the different samples were hermetically 
sealed into stainless aluminum pans for measurements. Samples were scanned under 
nitrogen from 0 to 200oC at 10oC min-1.  
 
7.2.5 In vitro cellular test  
 
7.2.5.1 Cell isolation and culture  
 Human conjunctival fibroblasts (HCFs) were cultured from human conjunctiva at 
the Singapore Eye Research Institute as described in Chapter 3. Cells used for in vitro 
testing in the study were between passage 4 and 5. 
 
7.2.5.2 In vitro cytotoxicity of PAMAM  
 HCFs were seeded directly onto the wells on a 96-well plate at a density of 103 
cells/well with 500 ml fibroblast medium consisting of DMEM supplemented with 
10% FBS, 1 mM L-glutamine, and 100 U/ml penicillin. The cells were incubated at 
37oC in a 5% CO2 incubator. After 2 days culture, the medium was removed and 
replaced with 500 µl fresh medium containing different concentration of PAMAM (0, 
10 µM, 10 µΜ, 50 µΜ, 100 µΜ and 1 mM). After up to 2 days incubation, the cells 
were observed under light microscopy and quantified by MTT assay as described 
previously. The relative cell viability (%) exposed to different concentrations of 
dendrimer was determined by comparing with a control containing no dendrimer.  
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7.2.5.3 Cell culture on crosslinked collagen scaffolds  
 After freeze-drying, the collagen sponge scaffolds were sterilized in 70% ethanol 
for 30 min and washed 3 times with sterile PBS solution followed by culture medium. 
HCFs were then seeded into the dish at a density of 5x103 cells/cm2 and were 
incubated in a 5% CO2 incubator at 37oC. The morphology of the adherent cells on 
various scaffolds was studied using scanning electron microscopy (SEM). To prepare 
the samples for SEM analysis, the scaffolds were washed twice by PBS followed by 
70% ethanol fixation for 5 h and dehydration in an ethanol ascending series of 75%-
100%. Finally the samples were freeze-dried, and platinum was sputtered onto the 
surface of the samples before SEM scanning.  
 
7.2.6 Statistical analysis 
 
 The collagenase degradation and cell proliferation were performed in triplicate and 
expressed as mean ± standard deviation (SD). Student’s t-test was employed to assess 
statistical significant difference of the results. Difference was considered statistically 
significant at p<0.05. 
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7.3 Results and discussion  
7.3.1 Shrinkage temperature and biostability of crosslinked collagen 
scaffolds  
 
 The phase transition temperature of the collagen scaffolds was measured using 
DSC. The phase transition temperature is related to the shrinkage temperature of 
collagen, at which collagen shrinks from the crystalline triple helix into amorphous 
random coils due to the breaking of interchain bonds. When collagen matrices are 
crosslinked, this shrinkage can be hindered and result in higher shrinkage temperature 
[277]. The shrinkage temperature of EDC/NHS and GTA crosslinked collagen in the 
presence/absence of dendrimer is summarized in Table 7.1. 
 
Table 7.1 Shrinkage temperature of the collagen scaffolds determined by DSC. 
 
Sample* 
Shrinkage temperature  







*COLL: noncrosslinked collagen scaffold, COLL-EDC: EDC crosslinked collagen 
scaffolds without dendrimer, COLL-D-EDC: EDC crosslinked collagen scaffolds with 
dendrimer, COLL-GTA: GTA crosslinked collagen scaffolds without dendrimer, 
COLL-D-GTA: GTA crosslinked collagen scaffolds with dendrimer. 
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 Our preliminary DSC experiment showed that 50 µΜ of PAMAM dendrimer was 
found to be adequate for collagen crosslinking. The ratio of NH2/COOH has been 
reported to influence the biostability of collagen [278]. Excess PAMAM may increase 
the cross-reaction among dendrimer molecules and reduce the crosslinking effect of 
collagen, resulting in the deterioration of collagen biostability. 50 µM dendrimer 
concentration was also found to induce minimal cytotoxicity as shown in the in vitro 
testing section. 
 
 A significant increase in the shrinkage temperature was observed after adding EDC 
or GTA, suggesting that crosslinking reaction occurred. However, the EDC crosslinked 
collagen (COLL-EDC) had a substantially lower shrinkage temperature compared with 
the GTA crosslinked collagen (COLL-GTA), indicating that EDC exhibited a lower 
degree of crosslinking compared with GTA. Therefore, though EDC induces a lower 
toxicity, EDC crosslinking of collagen may be limited for many applications due to its 
ineffective bonding and limited amine groups existing in collagen for crosslinking 
[279]. Incorporation of dendrimer led to a substantial increase in shrinkage 
temperature compared with its counterpart without dendrimer. For example, the EDC 
crosslinked collagen in the presence of 50 µΜ dendrimer (COLL-D-EDC) exhibited a 
higher shrinkage temperature of 82.7oC compared with the 73.3oC of COLL-EDC. 
This suggests that the efficiency of EDC/NHS crosslinking can be increased with the 
incorporation of dendrimer. The incorporation of dendrimer also increased the 
shrinkage temperature of GTA crosslinked collagen scaffold (COLL-D-GTA, 89.5oC) 
compared with the 84.3oC of COLL-GTA. With the use of dendrimer, it is likely that a 
lower amont of GTA is needed in order to maintain the same degree of crosslinking. 
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The lower amount of GTA may further translate to decreased toxicity and better 
biocompatibility of the scaffold compared with purely GTA crosslinking [280].  
 
7.3.2 Collagenase assay of crosslinked collagen scaffolds 
 
 The biodegradation of various crosslinked collagen scaffolds by collagenase is 
summarized in Figure 7.1, where a higher percentage mass loss represents higher 
degradation degree and lower biostability of collagen. After 1 day of digestion in 
collagenase, most of the noncrosslinked collagen scaffold (COLL) was degraded 
(92%). Approximately 44% of COLL-EDC was degraded, while only 20% of the 
COLL-GTA was digested. This confirms that the biostability of EDC crosslinking was 
lower compared with that of GTA crosslinking, and is agreeable with the shrinkage 
temperature result shown above. The addition of dendrimer significantly reduced the 
mass digestion of the collagen from 44% (COLL-EDC) to 21% (COLL-D-EDC) 
(p<0.05, Figure 7.1). COLL-D-EDC also exhibited a comparable degree of 
degradation with COLL-GTA (19%). The addition of dendrimer further increased the 
biostability of the GTA crosslinked collagen (COLL-D-GTA, 13%), but with only 6% 
enhancement (p<0.05). This suggests that the GTA crosslinking itself was highly 
effective and the additional effect from dendrimer was limited. The increase in 
biostability of collagen by the addition of PAMAM dendrimer is likely due to the 
increased crosslinking as discussed above since the high surface density of amine 

























Figure 7.1 Mass loss percentage of the collagen scaffolds after 1 day incubation in 
collagenase solution, mean for n= 3 ± SD. (*) p<0.05 compared with COLL-EDC; (^) 
p<0.05 compared with COLL-GTA. 
 
7.3.4 SEM morphology  
 
 The surface structure of the collagen scaffolds were observed by SEM as shown in 
Figure 7.2. All the collagen scaffolds exhibited porous spongy morphology with 
evenly distributed and interconnected pore structures of 50 to 150 µm. This pore 
dimension may accommodate cell seeding and facilitate migration into the scaffold 
[194, 195]. The pore of the noncrosslinked collagen scaffold (COLL) seemed to be 
clearly round or polygonal morphology (Figure 7.2a). After crosslinking by EDC or 
GTA with/without dendrimer, the pores exhibited a more sheet-like morphology as 
observed in Figure 7.2b-e. The structure of these crosslinked collagen scaffolds 
became denser compared with COLL, and this is likely due to the chemical 
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scaffolds with dendrimer (COLL-D-EDC, and COLL-D-GTA) exhibited a slightly 
denser structure than their counterparts without dendrimer respectively (COLL-EDC 
and COLL-GTA). This suggests that dendrimer could enhance the crosslinking of the 





















Figure 7.2 SEM micrographs of the collagen scaffolds, (a) COLL, (b) COLL-EDC, c) 
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7.3.5 In vitro cellular testing 
7.3.5.1 Cytotoxicity of PAMAM dendrimer  
 
 The cytotoxicity of dendrimer is an important concern since dendrimers have 
attracted much interest in biomedical applications, especially in therapeutic 
applications [265, 266, 281-283]. In this study, the cytotoxicity of PAMAM dendrimer 
was examined via cell viability in vitro. Figures 7.3 and 7.4 show the morphology of 
HCFs under phase contrast microscopy and cell viability after exposing to the various 





























Figure 7.3 Phase contrast micrographs (200x) of HCF morphology after 2 days 
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 Our microscopic observation shows that PAMAM dendrimer by itself caused cell 
morphology changes when the concentration of PAMAM dendrimer was as high as 1 
mM after 2 days incubation. As observed in Figure 7.3a, more rounded HCFs were 
seen in 1 mM dendrimer compared with the normal fibroblastic morphology of HCFs 
on the control sample without dendrimer (Figure 7.3b). No significant change of cell 
morphology was observed even after 5 days incubation when the concentration of 
PAMAM is below 100 µM (not shown). In Figure 7.4, after 2 days incubation, the low 
PAMAM concentration of 0.10 µM in a culture medium enhanced a higher cell growth 
(10%) (p<0.05), while the high PAMAM concentration of 1 mM induced a 
significantly lower cell viability (15%) compared with the control (p<0.05). The 
increased cell viability at the low concentration of dendrimer may be due to the 
increased cell interaction between the terminal cationic amine groups of the dendrimer 
and the cells. This interaction may lead to the increased cell adherence and 
proliferation as the immobilization of the dendrimer was previously reported to modify 
polystyrene plates for promoting cell adherence due to the electrostatic attraction [284]. 
In addition, the conjugation of growth factors/peptides onto terminal group of 
dendrimer has been used to provide higher selectivity and biological recognition [285, 
286]. Thus in our case, PAMAM dendrimer may also attract negatively charged 
proteins or growth factors in the serum to promote biological recognitions and lead to 
the increased cell growth.  
 
 At the high PAMAM concentration of 1 mM, decreased cell viability was observed. 
At such concentration, the cationic PAMAM dendrimer may lead to cellular bonding 
as labeled by the arrows in Figure 7.3a by electrostatic attraction because cells 
generally are negatively charged due to the presence of negatively charged glycoslated 
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intergral and peripheral proteins [287]. Similar cell aggregation was also observed 
among blood cells when PAMAM dendrimer was added during haemolysis analysis 
[288]. Even cell membrane damage was reported due to the excessive intercellular 
bonding in the presence of dendrimer [282]. In our case, such high concentration of 
dendrimer may induce excessive cell bonding or substantial cell membrane damage, 
and may result in the observed low cell viability. The difference in cell viability and 
morphology for 10 - 100 µM concentration of PAMAM was negligible compared with 
the control, indicating that PAMAM in this concentration level induced minimal 
cytotoxicity. Based on the above results, PAMAM dendrimer at 50 µM was selected 
for the crosslinking of collagen scaffolds especially when the release of dendrimer 























Figure 7.4 Cell viability of HCFs exposed to the different concentrations of dendrimer, 
pure collagen without dendrimer as control. Mean for n= 3 ± SD. (*) p<0.05 compared 
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7.3.5.2 Cell proliferation on collagen scaffolds 
 
 Figure 7.5 shows the cell proliferation of HCFs on the collagen scaffolds after 3 
days incubation. All the collagen scaffolds exhibited higher cell proliferation than the 
tissue culture plate (TCP) as shown in Figure 7.5. The effect of collagen on cell growth 
has been widely known. Being a native ECM, collagen acts as a natural substrate for 
cell recognition and binding, resulting in favorable adhesion and growth of many cell 
types. The EDC crosslinked scaffolds (COLL-EDC and COLL-EDC-D) exhibited 
higher cell growth than the noncrosslinked collagen (COLL). This is likely due to the 
increased biostability of collagen induced by crosslinking which may provide the 
persistent biological and physical support for cell growth. The fast collapse of the 
noncrosslinked collagen scaffolds due to degradation was observed by eye and resulted 
in cell detachment and attributed to the decreased cell growth on the COLL. Though 
the GTA crosslinking may increase the biostability of collagen and preserve the 
structural integrity of collagen, no significantly higher cell proliferation on the GTA 
crosslinked collagen (COLL-GTA and COLL-GTA-D) was observed. This is likely 
due to the cytotoxic effect of unreacted residual GTA. This further confirms that EDC 
crosslinking exhibited lower cytotoxicity compared with the GTA crosslinking, and 
similar results have been found by other investigations [195, 197, 289]. In comparison 
between the crosslinking with and without the use of PAMAM dendrimer, a higher cell 
proliferation was observed on the COLL-EDC-D than COLL-EDC, but no difference 
of cell proliferation was observed between COLL-GTA and COLL-GTA-D. The 
increased cell growth on the COLL-EDC-D can be attributed to the increased 
biostability of collagen nanofibers with dendrimer as discussed previously. 
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Figure 7.5 Cell proliferation on the collagen samples and TCP (control) after 3 days 
incubation, TCP: tissue culture plate. (*) p<0.05 compared with TCP; (#) p<0.05 
compared with COLL-EDC. 
 
 Cell morphology on the different collagen scaffolds was observed by SEM after 5 
days incubation (Figure 7.6). The surface of COLL exhibited denser and nonporous 
structure. This was due to the degradation of the noncrosslinked collagen scaffold that 
collapsed the scaffold into dense membrane-like structure (Figure 7.6e). Though some 
pores could still be traced on COLL-EDC, its structure became denser and thinner 
similar to that of COLL. The thickness of COLL-EDC (approximately 1 mm, not 
shown) was slightly greater than that of COLL (100 µm, Figure 7.6e), but significantly 
less than that of COLL-EDC-D (3 mm, Figure 7.6f). As shown in Figure 7.6c, the 
porous morphology of COLL-EDC-D could be observed after 5 days incubation and 
the original thickness of the scaffolds was still maintained. This suggests that the 
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collagen scaffold substantially, and leads to higher structural integrity as shown in the 
previous collagenase assay. No difference of morphology of the scaffolds was 
observed on the COLL-GTA (Figure 7.6d) and COLL-GTA-D (not shown). Finally, 
the 3-dimensional porous structure of the scaffolds (Figures 7.6c and d) displayed 
some degree of cell migration into the pores indicating closer cell-scaffold integration 
and possibly better tissue development. The study suggests that the resultant 
crosslinked collagen scaffolds with dendrimer could be used as novel functional 
biomimetic materials toward achieving excellent integration between cells and 






























Figure 7.6 SEM micrographs of HCFs proliferating on the collagen scaffolds and 
cross-section of the collagen scaffolds, (a) COLL, b) COLL-EDC, (c) COLL-D-EDC, 
(d) COLL-GTA, (e) Thickness of cross-section of COLL (100 µm), f) thick of cross-
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7.4 Conclusions 
 
 This chapter describes the modification of GTA and EDC crosslinking collagen 
through the incorporation of PAMAM dendrimer. The results show that the resultant 
collagen scaffolds exhibited highly porous morphology with pore size of 50 to 150 µm. 
Incorporation of PAMAM dendrimer enhanced the crosslinking degree for both GTA 
and EDC leading to higher biostability of collagen scaffolds. Our in vitro test shows 
that the incorporation of dendrimer to EDC crosslinked collagen scaffolds exhibited 
the best cell proliferation among all scaffolds studied, suggesting that it may be a better 
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Chapter 8  
 




 Substantial effort is being invested by the bioengineering community to develop 
suitable artificial scaffolds for tissue engineering applications. The potential of 
applying nanotechnology in fabricating scaffolds is huge in that it can not only mimic 
the nano-dimension of natural ECM, but can also form a well-defined architecture to 
guide cell growth and development as needed. Recently, with the development of new 
processing methods, it is possible to produce scaffolds that partially match 
characteristics of tissue-specific ECMs.  
 
 This thesis firstly investigated the nanofabrication, crosslinking modification and 
controlling architecture of novel nanofibrous collagen scaffolds used as substrates for 
culturing human corneal cells and subsequently for constructing corneal equivalents to 
restore the eyesight of patients who suffer corneal related diseases or accidents. We 
have shown that the crosslinked nanofibrous collagen scaffolds were found to enhance 
structural integrity of the nanofibrous scaffolds and maintain their nano-dimension and 
porous structure. Our study also confirmed that the corneal cells organized their 
growth on the aligned collagen nanofibers in order to follow the scaffolds orientation. 
In addition, the incorporation of glycosaminoglycan (GAG) into collagen nanofibers 
was also found to promote cell growth. 
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 The possible reason for the nanofibrous collagen scaffolds to be excellent for 
corneal cell growth is that the biological origin of collagen and its nano-dimension 
mimic closely the natural ECM, and thus cell-matrix interaction could be maximized. 
The intermolecular crosslinkages formed between the fibers after the crosslinking also, 
led to increased biostability favorable for cellular integration. In addition, GAG are 
glycoproteins with a protein core and polysaccharide branches composed of repeating 
disaccharide units containing carboxylic and/or sulfate ester groups. The bridging and 
linking of these functional groups to collagens may increase cell growth. The 
incorporation of some bioactive reagents may be significant in tissue regeneration and 
in providing better tissue engineered product. All these factors may all be attributed to 
the improved biological and physical properties of our nanofibrous scaffolds.  
 
 Our study confirmed the unique characteristics of electrospinning used for tissue 
engineering scaffolding and the convenience of incorporating various functional 
groups into the resultant scaffolds. It appears that well-defined architecture fabricated 
by electrospinning coincided with the unique structure found in native cornea, and 
allowed the guidance of cell growth and orientation. 
  
 There are some disadvantages of collagen nanofibers such as small pore size, and 
this resulted in limited cell migration and infiltration as discussed before. Collagen gels 
and sponges are still a commonly used scaffold in many biomedical fields. With 
respect to the limitation of collagen gels and sponges, one part work of this thesis was 
devoted to improve the physical properties of traditional collagen scaffolds, and a 
novel crosslinking technique with PAMAM dendrimers was also investigated. Our 
results showed that the increased degree of crosslinking and lower cytotoxicity of 
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glutaraldehyde (GTA) and carbodiimide (EDC) crosslinking collagen were achieved 
through the incorporation of PAMAM dendrimer with surface amino groups. This 
dendrimer may provide the increased bonds/bridges between collagen molecules 
and/or crosslinkers (EDC and GTA) with extra surface amino groups. Meanwhile, the 
extra amino groups could bond other peptides and growth factors, and promote cell 
growth and new tissue regeneration. Our in vitro test suggests that the resultant 
crosslinked collagen scaffolds with dendrimer possessed higher physical strength and 
biostability. The collagen gel or sponge may be more attractive in the fields ranging 
from drug delivery to molecular encapsulation and gene therapy, once the strength 
reinforcement of collagen composites can be performed. Besides, the biological 
characteristics of the dendrimer already indicated in the previous studies [290, 291] 
may lead to more potential applications in these fields due to the biological ligands of 
dendrimers with biospecific recognition, inhibition and targeting.  
 
8.2 Recommendations  
 
 The use of electrospinning within this thesis has shown that the potential use of 
nanofibrous collagen scaffolds as a new model for the alternative design of corneal 
replacements. However, collagen nanofibers still exhibited low mechanical strength 
due to inherent mechanical weakness of native collagen. The incorporation of GAG 
(such as CS) promoted cell growth but it did not increase the biostability of collagen 
nanofibers. Besides, the unique bridging structure of GAG found in native tissue was 
not observed in the blended CS/collagen nanofibers. A more effective crosslinking 
method should be needed to improve the mechanical strength and biostability of 
collagen scaffolds to pass the mechanical strength requirement for transplantation 
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surgery. Alternatively, the blending of synthetic biodegradable polymers, such as 
poly(lactic acid), with collagen may be useful to provide better scaffolds for tissue 
engineering. With combined characteristics of both polymers, it may provide better 
mechanical properties and sufficient biological recognition for cellular integration. 
Besides, the blended polymers most likely can yield better and easier processing 
conditions for electrospinning compared with the current process used for pure 
collagen. 
 
 Our studies here showed that the current electrospun collagen nanofibers only 
supported 2-dimensional cell growth and migration. Failure of cells migrating into the 
nanofibrous scaffold is a main shortcoming as the pores (roughly 1-5 µm) are too small 
compared with the size of cells (50-100 µm). 3-dimensional cell-matrix integration has 
already been found to play a significant role on cell behavior and tissue regeneration. 
Fabricating sheets of cell-aligned nanofibers stacked on top of each other to form a 
unique layer-by-layer architecture of cells and matrix may yield the desirable 3-
dimensional integrated structure that is found in corneal stroma. Alternatively, polymer 
solution and cell suspension may be co-electrospun to obtain integrated cell-matrix 
structures. This can allow cells homogenous distribution in the nanofibrous scaffolds 
and overcome the limitation of cells infiltrating into the electrospun nanofibers. But 
maintaining sterile environment through out the process can be difficult and the low 
survival rate of cell may occur during electrospinning.  
 
 With reference to the dendrimers incorporated into crosslinking of collagen, the 
mechanism of the increased crosslinking with dendrimer has not been investigated 
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completely in the study. Although the applications of dendrimers have been studied 
within a very broad range, the influence of dendrimer on biological systems has also 
remained largely unexplored. More detailed characterization of these scaffolds, such as 
mechanical properties, water uptake ability and biostability, should be investigated to 
further understand the crosslinking mechanism. Although low generation of 
dendrimers (generation 2) used in the study exhibited the common characteristics of 
dendrimers, higher generations of dendrimer with higher content surface groups and 
longer polymer chains should also be investigated to understand the steric effect and 
how it affects the availability of the amine groups for crosslinking. Finally, this 
crosslinking method used in collagen sponges can be implemented into collagen 
nanofibers to obtain mechanically stronger scaffolds.  
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